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General aspects of plasma triglyceride metabolism 
Plasma lipids consist of triglycerides, phospholipids, cholesterol, cholesterol esters and 
free fatty acids (FFA). Because of their water insolubility plasma lipids do not circulate 
as such but combine with proteins to form hydrophilic lipoprotein complexes. Plasma 
lipoproteins can be separated in different classes by ultracentrifugation or by electro~ 
phoresis. Four groups of lipoproteins are important in clinical diagnosis. They are: high 
density or C>-lipoproteins, low density or ~-lipoproteins, very low density or pre-~-lipo­
proteins and chylomicrons. The latter two groups have a higher fat and triglyceride 
content than the former two. In clinical situations, associated with an increased plasma 
triglyceride content, hyperchylomicronemia, hyper pre-~-lipoproteinemia or a combi-
nation of these will be found. 
The source of plasma chylomicro11s is dietary fat. Dietary triglycerides are hydrolysed 
into monoglycerides and fatty acids which are absorbed and reesterified into triglycerides 
in the small intestinal mucosa. The intestinal cells secrete most of these triglycerides as 
chylomicrons and a small fraction as very low density lipoproteins into lymph channels 
collecting into the thoracic duct and thence into the venous circulation. Plasma chylo-
microns consist of particles having a diameter of 750 to 12.000 A. Clearance of chylo-
microns from the plasma occurs mainly in the extrahepatic tissues and is mediated by the 
enzyme lipoprotein lipase. Hydrolysis of triglyceride molecules by lipoprotein lipase 
occurs concurrently with their uptake by the tissues. This process probably takes mainly 
place in the capillary endothelium of muscle and adipose tissue (Blanchette-Mackie, and 
Scow 1971). 
The main source of pre-(3-lipoprotein is the liver which synthesizes pre-(3-lipoprotein 
particles and secretes these into the blood stream. Fatty acids of pre-~-lipoprotein tri-
glycerides derive from two main sources: 
I Synthesis de novo from acetyl-CoA which is generated by glycolysis from carbo-
hydrates. This pathway plays quantitatively an important role in the fed state. 
2 Adipose tissue triglycerides lipolysis. This is regulated by a hormone sensitive tri-
glyceride lipase located in the fat cells. In situations chan,1cterized by an increased 
lipolysis (fasting, diabetes mellitus) plasma FFA represents the main source of plasma 
pre-!l-lipoprotein triglyceride fatty acids. Clearance of plasma pre-/l-lipoproteins tri-
glycerides in the extrahepatic tissues does not seem to differ qualitatively from that of 
chylomicron triglycerides (Havel, 1965). 
Triglyceride bloodlevels represent the sum of triglyceride molecules incorporated in the 
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different lipoproteins, chylomicrons and pre-~-lipoproteins having the highest triglyceride 
content. When no fat is consumed for a period of about 12 hours prior to blood-
sampling, chylomicrons have disappeared from the plasma. Consequently, in thefasting 
state plasma triglycerides are mainly derived from pre·.B·lipoproteins. 
Generally speaking the concentration of triglycerides in the plasma depends on two 
processes: 
I The rate of entry into plasma (production rate). 
2 The rate of efflux from plasma (clearance rate). 
In order to understand the pathogenesis of hypertriglyceridemia one should investigate 
·whether an increased plasma triglyceride level is due to an increased triglyceride produc-
tion rate, a decreased triglyceride clearance rate or both. In a steady state these two rates 
are equal and represent triglyceride turnover. Methods for the measurement of plasma 
triglyceride turnover involve different techniques such as measurement of disappearance 
rate of intravenously injected labelled lipoproteins, the determination of the rate of entry 
into plasma, or clearance from plasma of endogenous lipoproteins labelled from various 
precursors in vivo (Nikkilii eta!. 1971, Adams eta!. 1974). Among other techniques used 
in the investigation of plasma triglyceride metabolism, the intravenous fat tolerance test 
(introduced in clinical studies by Boberg et al. in 1969) has been used by many workers 
in the field. Studies of plasma triglyceride metabolism by these different techniques 
(labelled precursors on the one hand, the IVFTT on the other) have yielded concordant 
results in all situations where comparative studies have been performed (Nikkilii, and 
Kekki 1972, Kissebah et al. 1974, Kissebah et al. 1973) with the exception of idiopathic 
hypertriglyceridemia (Adams eta!., 1974). There is, at present, no clearcut explanation 
on this last point. We did not make use of labelled precursors in vivo in our studies of 
pediatric patients on the following grounds: 
1 Ethical problems associated with the use of radioactive products in children. 
2 The radioactive decay methods require a long fasting period (unacceptable for many of 
our patients, who were prone to hypoglycemia). 
We used the following two tests in our investigation. Firstly, we performed the intra· 
venous fat tolerance test (IVFTT) with lntralipid fat emulsion. With this method the 
fractional Intralipid turnover rate can be calculated. Secondly, by measuring the plasma 
postheparin lipoprotein lipase activity we tried to get more insight into the physiological 
significance of lipoprotein lipase which plays a predominant role in triglyceride elimi· 
nation from the blood. As it has been suggested by Boberg (1972) that blood samples 
taken 5 and 40 minutes after the intravenous injection of heparin could reflect 
lipolytic activities from different pools, not equally accessible for injected heparin, both 5 
and 40 minutes postheparin lipoprotein lipase (PHLPL) activities were measured in our 
investigation. Recent litterature data concerning these two tests are presented in the 
following chapter. 
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Chapter I 
The intravenous fat tolerance test and the plasma postheparin lipoprotein 
lipase activity 
1. The intravenous fat tolerance test 
1.1. Introduction 
Hypertrig]yceridemia in man has initially been investigated by oral fat tolerance tests 
(Angerwall, 1964). The serum triglyceride curves obtained after such tests depend on 
many factors such as intestinal absorption, lymph flow and triglyceride clearance. 
Because of these many operating factors oral fat tolerance tests are difficult to interpret 
and do not allow a precise estimation of triglyceride clearance. A better estimation of the 
latter can be obtained by performing an intravenous fat tolerance test bypassing in this 
way the gastrointestinal tract. 
1.2 Validation of Intralipid emulsion for the measurement of plasma triglyceride 
metabolism 
For a fat emulsion to be a valid reflector of chylomicrons metabolism it should have 
properties similar to chylomicrons. It has been shown that, when incubated in vitro with 
postheparin plasma, chylomicrons and Intralipid presented a similar enzymic kinetic 
behaviour whereas this was not the case with other fat emulsions (Boberg, and Carlson, 
1964). Furthermore, lntralipid elimination from the blood is known to follow identical 
kinetic rules as chylomicron elimination in the dog (Carlson, and Hallberg, 1963) and in 
man (Hallberg, 1965 b). These reported similarities in behaviour of chylomicrons and 
lntralipid probably validate the use of lntralipid fat emulsion for the measurement of 
chylomicron metabolism. The second question is whether Intralipid, being a good 
reflector of exogenous triglyceride elimination, is also a good reflector of endogenous 
triglyceride elimination. This is probably the case, as it has been shown that a good 
correlation exists between the lntralipid fractional turnover rate as measured by the 
IVFTT and the fractional turnover rate of endogenous triglycerides measured by several 
techniques (Rossner, 1974). It should be noted that contrary to the findings of Boberg 
and Carlson (1964), Huttunen and Nikkilii (1973) recently reported differences in 
enzymic kinetic behaviour between Intralipid and chylomicrons. These authors found 
affinity differences for lipoprotein lipase between lntralipid on the one hand and chylo· 
microns on the other. These divergent results seem to be due to differences in method-
ology. Huttunen and Nikkilii found that the addition of 1M NaCl in their test system 
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resulted in an increased lipolytic activity, while Boberg and Carlson (1964) reported a 
90% decrease of lipolytic activity under these conditions. As it is known that lipoprotein 
lipase is inhibited by NaCl the results of Huttunen and Nikkila (1973) are difficult to 
interpret. Although we realize that the discrepant results of different authors cannot be 
fully explained at present, we used Intralipid emulsion to perform the intravenous fat 
tolerance test in order to investigate plasma triglyceride removal. 
1.3 Kinetics of the elimination of exogenous lipids from the blood 
The kinetics of the elimination of exogenous lipids from the blood after intravenous 
injection has been studied by Hallberg (1965a). Elimination is regulated by two rate 
constants according to this author. A zero order reaction takes place at high plasma 
triglyceride concentrations, a first order reaction at low plasma triglyceride concen~ 
trations. The zero order part of the elimination has been interpreted to be a maximal 
elimination capacity operating above a critical Intralipid concentration. This elimination 
constant has been designated as K1 • Below the critical concentration a first order reaction 
takes place, its elimination constant has been designated as K2 • If a low Intralipid dose 
(0.1 gr/kg body weight) is used the IVFTT only measures K2 • If higher Intralipid doses 
are used one can measure both K1 and K2 • Boberg et al. (1969) used the IVFTT with 
high fat doses. It appeared that K1 was the same in young and old controls and normal in 
patients with primary hypertriglyceridemia. On the other hand K2 was found to be 
subnormal in old when compared to young controls, the former having higher triglyceride 
bloodlevels in the fasting state. K2 was also found to be subnormal in patients with 
primary hypertriglyceridemia (see 1.5.1). It thus appeared that K1 and K2 values were 
not correlated, and that K2 yielded important clinical information on the pathogenesis of 
hypertriglyceridemia, whereas K1 did not. In our clinical studies we measured K2 only 
when performing the IVFTT (see chapters 2 and 3). 
1.4 Methodology of the intravenous fat tolerance test 
A methodological study of the IVFTT with Intralipid fat emulsion has been performed 
by Carlson and Rossner (1972). After a single intravenous injection of 0.1 g Intralipid per 
kg body weight the turbidity of bloodsamples taken during the following 40 minutes was 
determined nephelometrically. The following points were clarified. Firstly, identical 
results were obtained with venous plasma and capillary whole bloodsamples. This makes 
the test easy to perform in children. Secondly the test has been shown to be highly 
reproducible in the same individual from one day to another. 
1.5 Situations characterized by a decreased value of the IVFTT. 
Correlation with triglyceride blood/evels 
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1.5 .1 Primary hypertriglyceridemia 
A decrease of the IVFTT value in patients with primary hypertriglyceridemia has been 
found by many investigators. Boberg (1969) published the first study on this subject. He 
found K2 to be significantly decreased in hyperlipemic patients. When K2 values and 
plasma triglyceride concentrations were plotted against each other, K2 was found to 
decrease with increasing concentration of plasma triglycerides in a hyperbolic fashion. 
The same inverse relationship between K2 and serum triglyceride level in a group of 
normal, hyperlipemic and diabetic adult patients was found by Lewis et a!. (1972). 
Adams et a!. (1974) performed and extensive study of triglyceride transport kinetics in 
patients with type IV and type V hyperlipoproteinemia. Triglyceride removal as measured 
by the !VFTT was found to be decreased in both hyperlipoproteinemias. 
1.5.2 Dietary influences 
Neste! and Barter (1973) studied triglyceride clearance during diets rich in carbohydrates 
or fats. Clearance rates of lntralipid fat emulsion were measured from steady state tri~ 
glyceride increments during constant infusion of the fat emulsion. Diets rich in poly-
unsaturated fat lead to a faster Intralipid clearance than high carbohydrate diets or diets 
rich in saturated fat. 
Mancini et a!. (1973) studied the mechanisms of carbohydrate induced hyperlipemia in 
normal man. High carbohydrate diets lead to higher triglyceride bloodlevels and to a 
decrease of Intralipid clearance as measured by the IVFTT. 
Cahlin et al. (1973) studied, among other things, the effect of sucrose feeding on removal 
of intravenous fat in man. They showed that sucrose feeding leads to a decrease of the 
IVFTT value. 
1.5.3 Obesity 
Rossner eta!. (1974b) studied the IVFTT in subjects with massive obesity. The patients 
were studied before and after a jejuna-jejunal bypass operation. Before operation high 
triglyceride bloodlevels were found concomitantly with a decrease of the IVFTT value. 
There was a negative correlation between triglyceride bloodlevels and values of the IVFTT. 
With postoperative weight reduction, plasma triglyceride levels decreased significantly 
while the IVFTT values rose. The changes varied considerably in different patients, how-
ever, some patients losing much weight without showing changes of the IVFTT value 
while others with a very moderate weight loss showed a marked rise of the lVFTT value. 
1.5.4 Maturity onset diabetes mellitus 
In 1972 Guisard et a!. showed that in adults with maturity onset diabetes lntralipid 
clearance was decreased. Kissebah et a!. (1974) studied plasma FFA and triglyceride 
transport kinetics in maturity onset diabetes. In non obese diabetics the IVFTT value was 
found to be decreased. In obese diabetics a slight decrease of the IVFTT value was found. 
Basal triglyceride levels, though increased in both groups of patients, were highest in the 
non obese group who showed the most important reduction of the IVFTT values. 
1.5.5 Hypothyroidism 
Nikkilii and Kekki (I 972) studied plasma triglyceride metabolism in thyroid disease. In 
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hypothyroid patients triglyceride bloodlevels were elevated. Triglyceride removal as 
measured by the IVFTT was found to be decreased. There was no significant correlation 
between triglyceride bloodlevels and the IVFTT values. 
1.5.6 Alcoholic hyperlipemia 
Chait A. et al. (1972) performed a metabolic study of alcoholic hyperlipemia. The value 
of the IVFTT was found to be decreased before as well as after alcohol withdrawal. 
Triglyceride bloodlevels on the other hand decreased very significantly after alcohol 
withdrawal. Thus no correlation was found between triglyceride bloodlevels on the one 
hand and the IVFTT value on the other. 
I. 6 Situations characterized by an increased value of the JVFTT. 
Correlation with triglyceride bloodlevels 
1.6.1 Dietary influences 
Neste! and Barter (1973) studied the effect of different diets on Intralipid elimination. 
Diets rich in unsaturated fat resulted in the highest Intralipid fractional removal rates and 
the lowest fasting plasma triglyceride levels (see also 1.5.2). 
1.6.2 Thyrotoxicosis 
Nikkilii and Kekki (1972) studied plasma triglyceride metabolism in thyroid disease. In 
thyrotoxicosis the IVFTT values were higher than normal. Triglyceride bloodlevels were 
slightly increased (see also 1.5.5). 
1.6.3 Pharmacologic agents 
Many pharmacologic agents have been shown to lower plasma triglyceride levels and 
increase the IVFTT concommitantly. These agents are for example: nicotinic acid and 
clofibrate derivatives (Boberg et al., 1970), oxandrolone (Olsson et al., 1974), progeste-
rone or megestrol (Kissebah et al., 1973). 
1. 7 Discussion 
The fmt clinical studies using the IVFTT in the investigation of primary hypertri-
glyceridemia showed that there exists an inverse relationship between triglyceride blood· 
levels and the IVFTT values (Boberg et al., 1969). This finding can be interpreted in two 
ways. A decreased triglyceride elimination rate could induce hypertriglyceridemia or the 
reverse sequence could be the case. In the former case the IVFTT would be a valuable 
tool in the investigation of hypertriglyceridemia. In the latter case the lowering of the 
IVFTT value could simply be explained by a competitive effect of endogenous tri-
glyceride with Intralipid for common removal sites (Adams et al. 1974). The IVFTT 
would merely be a reflection of endogenous triglyceride pool size and not of triglyceride 
removal efficiency. If the IVFTT value merely reflects the triglyceride bloodlevels one 
should expect the original inverse relationship found between the IVFTT values and 
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triglyceride bloodlevels in primary hypertriglyceridemia to be a constant finding in all 
clinical situations presenting with hypertriglyceridemia. The following studies do not 
support his hypothesis. 
A study on alcoholic hyperlipemia (Chait et al., 1972) has demonstrated that in that 
situation triglyceride bloodlevels and the IVFTT values were unrelated and furthermore 
that the IVFTT could remain unaffected by major variations of triglyceride bloodlevels. 
A study on the mechanism of hypertriglyceridemia associated with the use of contraw 
ceptive steroids (Rossner et al., 1971) has further demonstrated that the IVFTT could 
remain unaffected by changes in triglyceride bloodlevels. The study performed by Neste! 
and Barter (1973) on the effects of different diets on Intralipid clearance revealed that 
changes in Intralipid clearance rates cannot be fully explained by changes in triglyceride 
pool size. 
In a study of patients with thyroid diseases Nikkilii and Kekki (1972) showed that 
elevated triglyceride bloodlevels can be found concomitantly with elevated IVFTT values 
(thyrotoxicosis). Consequently, the IVFTT seems to be relatively independent of tri-
glyceride pool size and probably measures triglyceride removal efficiency. Investigation of 
hypertriglyceridemia with the IVFTT can lead to one of the following possible results: 
High triglyceride bloodlevels are negatively correlated with decreased IVFTT values. In 
this situation an inefficient triglyceride removal is probably the most important 
pathogenetic factor. 
2 High triglyceride bloodlevels are unrelated to normal or even increased IVFTT values. 
In this situation triglyceride hyperproduction is probably the most important patho-
genetic factor. 
3 High triglyceride bloodlevels are not correlated with decreased IVFTT values. In this 
situation the hypertriglyceridemia is probably due to both an increased triglyceride 
production and an inefficient triglyceride removal. 
2 Plasma postheparin lipoprotein lipase 
2.1 Introduction 
The discovery of the 'clearing factor' dates back to 1943. Lipoprotein lipase or 'clearing 
factor' was discovered during research aimed at explaining the mechanism by which 
heparin injection reduced lactescence in hyperlipemic plasma (Hahn, 1943). Since then 
much work has been performed and a few review articles on the subject have been 
published (Robinson 1963, Persson 1971 ). Lipoprotein lipase is one of several triglyceride 
lipases with the following properties (Korn, 1955). It specifically requires lipoprotein and 
heparin as 'cow factor' and it is inhlbited by a high NaCl concentration and protamine. The 
function of LPL is to hydrolyse triglyceride molecules of plasma lipoproteins. This 
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hydrolysis takes place at the capillary endothelium of LPL containing tissues. The most 
important of these are adipose tissue, muscle, the mammary gland, heart and aorta. 
Because LPL plays such an important role in the removal of plasma triglycerides its 
activity should be studied in situations associated with abnormal triglyceride bloodlevels. 
In clinical studies there are two possible ways of investigation. LPL can be measured in 
adipose tissue biopsies or in plasma. The last approach has been most often chosen. In 
preheparin plasma LPL activity is very low. After heparin injection LPL activity in plasma 
rises rapidly. The precise mechanism involved is unknown. 
In the last few years terminology has changed from PHLPL to postheparin lipolytic activity 
(PHLA) or postheparin triglyceride lipase activity. The reason for this is that evidence for 
the presence of at least two triglyceride lipases in postheparin plasma has been provided 
(LaRosa et al., 1970). One of these triglyceride lipases has been shown to have 
prOperties specific of lipoprotein lipase, the other not. The latter seems to be of hepatic 
origin. Consequently, when measuring postheparin lipolytic activity one measures a 
higher total activity than that due solely to LPL. 
When referring to literature data we shall keep to the terminology used by the original 
author. Comparison between different authors' findings is difficult as different heparin 
doses have been used and bloodsamples have not been collected at the same thnes after 
heparin injection. It has been shown that the use of different heparin doses or blood-
sampling times result in the measurement of different PHLA in rat (Jansen and 
Hiilsmann, 1974) and in man (Krauss et al., 1974). Furthermore, the methodology for 
the measurement of PHLPL activity is not standardized. All these factors can lead to the 
finding of vecy different PHLPL activities in similar clinical situations. Finally, it should 
be pointed out that PHLPL represents the overall result of enzyme activity changes in 
different tissues. Total PHLPL activity can consequently remain unaffected when enzyme 
activity changes occur in opposite directions in different tissues. This is probably one of 
the reasons why the functional significance of PHLPL is at present poorly understood. 
2. 2 Situations characterized by a decreased plasma PHLPL activity. 
Correlation with triglyceride bloodlevels 
2.2.1 Idiopathic hypertriglyceridemia (primary hyperlipoproteinemia with elevated 
plasma triglyceride concentration) 
Boberg (1972) measured PHLPL activities in patients with hypertriglyceridemia. 
Activities were measured in bloodsamples collected 5 and 40 minutes after i.v. injection 
of 100 units heparin/kg body weight. Lower PHLPL activities were found in men and 
women with idiopathic hypertriglyceridemia. A significant negative correlation between 
40 minutes PHLPL activities and the logarithm of plasma triglyceride concentrations was 
found in men and women. 5 minutes PHLPL activities correlated negatively with plasma 
triglyceride concentrations in women only. Adams et al. (1974) measured plasma 
postprandial lipolytic activity in the same clinical situation. Heparin dose was 10 U/kg 
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body weight, blood was collected 10 minutes after heparin injection. Significantly 
decreased PHLA were found in patients with type IV and type V hyperlipoproteinemia. 
Other authors, however, reported postheparin lipolytic activities to be normal or elevated 
in primary hypertriglyceridemia (Havel 1969, Ahrens et al. 1961, Krauss et al 1974 b) 
2.2.2 Dietary influences 
Mancini et al. (1973) showed that isocaloric replacement of fat by carbohydrate in the 
diet led to a reduction of PHLA while triglyceride bloodlevels increased. 
The heparin dose was 10 U/kg body weight, bloodsamples were collected 10 min. after 
heparin injection. 
2.2.3 Diabetes mellitus 
Kissebah et al. (1974) measured PHLA in maturity onset diabetes. The heparin dose was 
lOU/kg body weight, bloodsamples were collected 10 min. after heparin injection. 
PHLA was significantly decreased while triglyceride bloodlevels were elevated. Patients 
with the highest triglyceride bloodlevels (non obese diabetics) had the lowest PHLA. 
Decreased PHLA in diabetes has also been found by Guisard et al. (1972). 
2.2.4 Hypothyroidism 
Nikkilii and Kekki (1972) studied PHLA in thyroid disease. The heparin dose was 
20 U/Kg body weight; blood was collected 10 min after heparin injection. 
In the hypothyroid state PHLA was decreased, while triglyceride blood levels were 
elevated. No correlation between PHLA and triglyceride bloodlevels was found however. 
2.2.5 Oral contraceptives 
Kissebah et al. (1973) measured PHLA in women taking contraceptive steroids. The 
heparin dose was 10 U/kg body weight. Blood was sampled 10 min. after heparin injec· 
tion. Estrogen administration was associated with a significant reduction of PHLA while 
triglyceride bloodlevels increased. 
In a similar investigation Rossner et al. (1971) studied PHLPL activity in bloodsamples 
taken 5 and 40 minutes after intravenous injection of 100 U heparin/kg body weight. 
After Estrogen administration a significant decrease of PHLPL activity was found in the 
40 minutes' samples only. Triglyceride bloodlevels increased in this situation. 
2.2.6 Chronic nonnephrotic renal failure 
Gutman et al. (1973) measured PHLA in chronic nonnephrotic renal failure. The heparin 
dose was 10 U/kg body weight, blood was sampled 10 minutes after heparin injection. 
Low PHLA associated with hypertriglyceridemia was found. 
2.3 Situations characterized by an increased plasma PHLPL activity. Correlation 
with triglyceride bloodlevels 
2.3 .1 Dietary influences 
Cybulska et al. (1974) studied the influence of feeding soybean oil on plasma postheparin 
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lipolytic activity. Heparin dose was 10 U/kg body weight, blood was collected 10 minutes 
after heparin injection. 
Isocaloric replacement of saturated fat by soybean oil in the diet for 10 days resulted in a 
significant increase of plasma PHLA while plasma TG levels decreased. 
2.3.2 Obesity 
Rafaeli-Eskhol and Diengott (1972) studied PHLA in obese patients. 
The heparin dose was I 0 U /kg body weight, blood was collected I 0 minutes after heparin 
injection. PHLA was found to be significantly higher in obese patients when compared to 
values of control subjects. Total fasting resulted in a decrease of PHLA to normal values. 
These values remained normal after the patients were put on a low caloric diet for a few 
weeks. Triglyceride bloodlevels were not mentioned. 
2.3.3 Hyperthyroidism 
Plasma PHLA was found to be significantly increased in thyrotoxicosis (Nikkilii and 
Kekki, 1972). The heparin dose was 20 U/kg body weight, blood was collected 
10 minutes after heparin injection. Triglyceride bloodlevels were slightly elevated. 
2.3.4 Contraceptive steroids 
Kissebah et al (1973) measured plasma PHLA in women taking contraceptives 
steroids. Women using either progesterone or megestrol showed a decrease in serum 
triglyceride concentration associated with an increased plasma PHLA. The heparin dose 
was I 0 U/kg body weight, blood was collected 10 min. after heparin injection. 
2. 4 Discussion 
Notwithstanding many methodological differences involved in the measurement of PHLA 
it is worth pointing out that there is a good agreement between the results from different 
authors. 
Although the functional significance of PHLA is not well known, changes of PHLA have 
most frequently been accompanied by changes of the IVFTT in the same direction (see 
summary table). 
Although it could be argued that a low PHLA is an artefact due to the fact that, when a 
high triglyceride concentration is present in the plasma, the enzyme could be relatively 
inactive towards added substrate in the in vitro test system, this is unlikely for the 
following reasons: 
In the presence of hypertriglyceridemia a normal PHLA (Krauss et al., 1974) or even a 
high PHLA (Nikkila and Kekki, 1972, Rafaeli-Eskhol and Diengott 1972) can be found. 
2 The effect of adding chylomicrons or VLDL in vitro on the total plasma PHLA seems 
to be insignificant (Krauss et al., 1974b ). 
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Consequently, it seems that in most situations, the PHLA can be regarded as a fairly 
reliable indicator of triglyceride removal efficiency. 
SUMMARY TABLE 
CLINICAL CONDITION PHLA IVFTT 
High carbohydrate diets -1 -1 
High PUF 1 diets2 t t 
Primary hypertriglyceridemia 
-1- -1 
Obesity2 t -1 
Diabetes mellitus + -1 
Hypothyroidism 
-1 t 
Thyrotoxicosis t t 
Alcoholic hyperlipemia 2 -1 -1 
Chronic non~nephrotic -1 ? 
renal failure 
Contraceptive steroids: 
1 Estrogens -1 N 
2 Progesterone t t 
Oxandrolone t t 
Nicotinic acid, clofibrate t 
PUF: Polyunsaturated fat 
2 Results of PHLA and IVFTT taken from different sources 
t increased activity 
..!- decreased activity 
N normal activity 
TG~blood~ References level 
t Mancini et al. 1973 
-1- Nestel and Barter 1973, 
Cybulska eta!. 1974 
t Adams et al. 1974 
t ROssner et al. 1974, 
Rafaeli Eskhol and 
Diengott 1972 
t Kissebah 1974 
t Nikkilii and Kekki 1972 
t Nikkilii and Kekki 1972 
t Krauss 1974 a, Chait 
et al. 1972 
t Gutman et al. 1973 
t Kissebah et al. 1973 
-1 Kissebah et al. 1973 
t Olsson et aL 1974, 
Glueck et al. 1973 
-1 Boberg et al. 1970 
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Chapter II 
Investigations and methods 
I Problem definition 
Investigation of triglyceride clearing was performed in three different groups of children 
presenting with specific problems related to triglyceride metabolism. 
I. 1 Children with glycogen storage disease 
Hyperlipemia in tbese children is a well known finding. 
The pathogenesis of hyperlipemia in patients with a glucose - 6 -phosphatase deficiency 
seems to be as follows: 
In the fasting state, tbe glycogenolyses of glycogen to pyruvate is increased because the 
conversion of glucose - 6 - phosphate to glucose is blocked. 
Part of the excess pyruvate is converted into acetyi-COA and thence into fatty acids. 
Hypersecretion of pre-~-lipoprotein by the liver ensues. (Fernandes and Pikaar, 1969). 
In patients with a deficiency of debranching enzyme or of the phosphorylase system, 
glycolysis is enhanced postprandially inducing liponeogenesis and hypersecretion of 
pre-~-lipoprotein by the liver. (Fernandes and Pikaar, 1969). 
Although enhanced triglyceride production by the liver plays an important role in the 
pathogenesis of hypertriglyceridemia of glycogen storage disease, it may not be the only 
factor. 
The question to be answered was the following: 'Does a decreased triglyceride elimination 
contribute to the development of hyperlipemia in these patients? ' 
1.2 Children with obesity 
As many questions related to this condition in children are still unanswered we tried to 
give, at least a partial answer, to the following questions: is hyperlipemia a common 
finding in childhood obesity? Is the fractional Intralipid turnover rate abnormal? 
Is the triglyceride production rate increased? 
Is the PHLPL activity abnormal? 
If this is the case is there a relation between PHLPL activity and increased insulin 
secretion? 
Do the abnormalities disappear after caloric restriction? 
21 
1.3 Children treated by total parenteral nutrition (P.N) for a prolonged period 
In this last study we tried to answer the following questions. 
Does the triglyceride clearing capacity of a patient change during PN' 
Is PN with high fat doses feasible without causing hyperlipemia? 
Is there an easy way to monitor the daily doses of fat emulsion during PN in such a way 
that Intralipid tolerance is not exceeded? 
2 Methods 
2.1 The JVFTT 
The test procedure in our study has been as follows: 
2.1.1 Subject procedure 
All children were studied in the morning about 2 hours after a small standard carbo-
hydrate breakfast. 
The reason for this was that patients with GSD frequently cannot tolerate a much longer 
period of fasting. 
As it has been shown that an acute glucose load does not affect the IVFTT value (Gibson 
et al., 1974) we assumed that a small carbohydrate breakfast would not affect Intralipid 
removal. A scalp vein infusion set was introduced into an antibrachia! vein. A basal 
bloodsample was taken for the determination of plasma lipids and of plasma nephelo-
metric blank value. 
An Intralipid (Jntralipid 20%) dose of 0.1 gr/kg body weight was injected intravenously 
within 45 to 60 seconds. The same lntralipid batch was used in all tests. 
Bloodsamples of 0.1 ml were pipetted after 5, 10, 15, 20, 25, 30 and 35 minutes. The 
samples were directly transferred to test tubes containing 5 ml NaCl 0.9%, mixed by 
turning and taken to the laboratory. 
2.1.2 Laboratory procedure 
Intralipid standard curve 
Standard solutions were prepared by diluting lntralipid 20% with saline as follows: 
To six tubes, each containing 5 ml of saline were added 10, 20, 30, 40, 50 and 60111 of 
lntralipid 20%. Intralipid concentrations in these tubes were 40, 80, 120, 160, 200 and 
240 mg/ 100 ml. 
From each tube 50111 was pipetted and added to 5 ml saline (dilution 1/100 ). The nephelo-
metric readings of these diluted Intralipid emulsions were performed in a Vitatron photo· 
meter equipped with an adaptor for nephelometry. A saline blank was used to set the 
zero. 
Standard solution 240 mg/ 100 ml (before dilution) was given an arbitrary value on the 
Vitatron scale. The nephelometric values of the other standard solutions were then 
measured. 
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It appeared that the standard cuiVe was linear and included the origin. Therefore, when 
determining the Intralipid content of bloodsamples it is sufficient to measure the 
nephelometric value of only one standard. 
In our experiments we compared the nephelometric readings of the bloodsamples to the 
value of the 240 mg/100 ml standard emulsion. With this standard, the Vitatron scale was 
set at 80, consequently all readings had to be multiplied by three in order to obtain the 
Intralipid concentration of the bloodsamples. 
Measurement of bloodsamples turbidity 
Bloodsamples (o.l ml blood in 5 ml saline) were centrifuged at low speed (60 g) for 10 
minutes. The supernatant was pi petted off and centrifugation was repeated. The super-
natant was then transferred to tubes which were placed in the photometer for nephelo-
metry. 
The blood blank value was substracted from each reading. 
Nephelometric readings were then converted to Intralipid concentration as described 
above. 
Intralipid concentrations during the IVFTT were not corrected for hematocrit values. 
When Intralipid bloodlevels were determined in the course of longterrn parenteral 
nutrition correction for hematocrit was performed, however. 
The results of the IVFTT were expressed as follows: 
The Intralipid concentrations were plotted on a logarithmic scale against time on a linear 
scale. The slope of the resulting straight line was determined by the method of least 
squares. The correlation coefficient of this line was calculated. The slope of the regression 
line represents the fractional removal constant which has been expressed as % removal/ 
minute. 
2. 2 Calculation of triglyceride production rate 
It has been shown (Rossner S. et al, l974a) that a correlation exists between endogenous 
and exogenous (IVFTT) triglyceride clearance. 
Consequently, by multiplying the basal plasma triglyceride concentration (mmoles/l) by 
the IVFTT value one gets a rough estimation of the relative plasma triglyceride elimi-
nation rate (mmoles/l plasma/minute). We assumed endogenous plasma triglyceride to be 
in a steady state just before performing the IVFTT. Consequently, the calculated plasma 
triglyceride elimination rate (mmoles/l plasma/min) is equal to the triglyceride produc· 
lion rate (mmoles/l plasma/min). The following limitations apply to this arbitrary 
measurement of triglyceride production rates. 
1 Although a good correlation was found between endogenous and exogenous tri· 
glyceride elimination (Rossner eta!., l974a) in control patients and in patients with 
primary hypertriglyceridemia this might not be true for other situations. 
2 As exogenous triglyceride (IVFTT) is eliminated more rapidly than endogenous tri· 
glyceride (Rossner S. et a!., 1974) the triglyceride production rates calculated in this 
way most probably overestimate the real values for endogenous triglyceride produc-
tion. 
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3 As plasma volumes of our patients were not measured the triglyceride production 
values could not be expressed in absolute terms but only as relative quantities 
produced/! plasma/min. Expression in this way ,however, might be advantageous for the 
following reasons. 
As children of different ages were investigated, comparison between these children was 
only possible by relating the triglyceride production to a quantifiable body measurement. 
The choice of plasma volume as quantifiable body measurement seems well indicated as 
the triglyceride production/ l plasma probably better defines the relationship between tri-
glyceride production and triglyceride bloodlevel than absolute triglyceride production 
rates. Notwithstanding these limitations calculation of triglyceride production rates as 
performed in this study probably represents a valuable and simple way of investigating 
plasma triglyceride metabolism in children with different diseases associated with hyper-
triglyceridemia. 
2. 3 Measurement of plasma postheparin lipoprotein lipase activity 
2.3.1 Subject procedure 
In most children the PHLPL test was performed one hour after the IVFTT (see 2.1.1). 
In patients with GSD, however, the two tests were performed on separate days in order to 
keep the fasting period as short as possible (see 2.1.1 ). 
A scalp vein infusion set was introduced into an antibranchial vein. At zero time 100 U of 
heparin per kg body weight was injected intravenously. 2.7 ml of blood was taken .for 
LPL activity analysis 5 and 40 minutes after the heparin injection and transferred into 
glass tubes containing 0.3 ml of 0.1 molar trisodium citrate. The bloodsamples were kept 
on ice. At the end of the test the bloodsamples were centrifuged and the plasma was 
frozen. LPL activity was determined within one month. 
2.3.2 Laboratory procedure 
When a choice has to be made between the many methods for the determination of 
PHLPL activity, a few points have to be considered, viz.: 
I The determination should be done in citrated plasma and not in serum. Apparently 
during the clotting process an inhibitor of lipoprotein lipase is released (Engelberg, 
!955). 
2 The triglyceride emulsion (substrate) should closely ressemble chylomicra, which are 
believed to be the physiological substrate. Intralipid seems to fulfill this requirement 
(Boberg and Carlson 1964, and Biale and Shafrir 1969). 
3 The substrate triglyceride concentration should be sufficiently high to obtain a zero 
order reaction for at least one hour (Boberg and Carlson, 1964 ). 
4 The triglyceride emulsion should be activated by incubation at 37° C with either high 
density lipoprotein (Kom, 1959) or by whole serum exactly as described by Jansen 
and Hiilsmann, (1973a). 
5 Relatively high concentration of albumin should be present in the assay mixture to 
bind released FFA (Kern et al., 1961). In the present investigation, mainly Jansen and 
Hiilsmann's method has been followed with a few minor modifications. 
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Materials 
1 Glycerol-tri (oleate 1-C-14) Amersham, circa 40 Mci/mMol 
2 Intralipid (Vitrum, Stockholm) 10% 
3 0. 2M Tris-bu[[er pH 8.5 
4 10% solution of bovine serum albumin (Cohn fract. V Serva Feinbiochemica, Heidel-
berg) in 0.2 M tris-buffer. 
5 Human inactive serum. Citrated plasma was clotted at 37° for 30 min. by the addition 
of CaC1 2 • The concentration of CaC1 2 was 0.025 M. After centrifugation the super-
natant was dialysed at 4°C during 24 h. against 0.9% NaCI. By addition of dilute KOH 
the pH was brought to 8.5. 
6 Amberlite1RA-400 (OH). Amberlite IRA-400 (Cr) was treated 7 times with a fivefold 
quantity of NaOH 5%. After washing with aq.dest. until neutral, water was removed 
by washing with isopropanol. Subsequently, the resin was washed with hexane and air 
dried. It was stored at -l5°C. 
7 Dole-mixture: 400 ml isopropanol, 100 ml heptane, 10 ml2N H2 S04 • 
Method 
A benzene solution of circa 3.5 MCi labelled tri-oleate was dried in a plastic tube in a 
nitrogen current. After addition of 1.1 rnl Intralipid 10%, the mixture was sonicated in a 
Branson sonifier, setting 2, (8 times for circa 45 11 , with intermittent cooling in ice). 
Subsequently, 3.0 ml of the inactive serum (5) 
6.0 m1 of the albumin solution ( 4) 
and 1.9 ml 0.2 M Tris-buffer (3) were added. 
0.8 ml was introduced into glass-stoppered tubes and incubated for 40 min. at 37°C. 
0.2 ml of the plasma samples were added and the reaction allowed to proceed for 35 min. 
at 37°C. 0.2 ml of distilled water served as a blank. The reaction was stopped by the 
addition of 5 ml Dole-mixture *). After shaking vigorously for circa 1 minute, 3 ml of the 
upper phase was introduced into a counting vessel containing 0.5 gr of Amberlite 
IRA-400 (OH-). 
These vessels were stirred from time to time. After 1 h. the supernatant was removed, the 
resin was washed 4 times with 5 ml of hexane. Subsequently, 1 ml of hyamine hydroxide 
solution (1M in methanol, Packard) was added and after circa 1 min. 10 ml of toluene 
with fluors. 
*) Followed (after circa 2 min.) by 3 ml heptane and 2 ml water. 
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After standing for at least 48 h. at 4°C and in the dark, the samples were counted. 
(Packard liquid scintillation counter). 
lf a f.lCi labelled tri-oleate (bf.lCi/mMol) has been used and the dpm counted was equal to 
c, then the lipolytic activity (f.leq fatty acid/min/liter is: 
c X 
( a 110 ) 3X b+Q.884 X 1000 
1000 a X 2200 X 0.2 X 35 X 0.956* X 0.75** X 0.9*** 
Precision of the method measuring PHLPL activity: the precision of the method used has 
been evaluated by calculating the coefficient of variation from !50 duplicate determina-
tions. 
The coefficient of variation was± 3.7%. 
*) 0.956 Efficiency of binding fatty acid to the resin 
**) 0. 75 Aliquot of the heptane supernatant 
***) 0.9 Concentration of plasma in citrated plasma 
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Chapter III (I) 
Hepatic glycogcnosis 
hyperlipidemia 
postheparin lipoprotein lipase 
triglyceride 
Triglyceride Clearing in Glycogen Storage Disease 
P. P. fORGET,1 171 J. FERNANDES, AND P. HAVERKAMP BEGEMANN 
Department of Pediatrics, Sophia Children's Hospital and Neonatal Unit, Medical School, 
Erasmus University, Rotterdam, The Netherlands 
Extract 
Peripheral uptake of triglyceride from plasma was investigated by intravenous fat 
tolerance tests and by postheparin lipoprotein lipase measurements in children with 
differenl types of glycogen storage disease. 
The patients with a glucose 6-phosphatase deficiency were characterized by a 
significantly diminished triglyceride eliminatiun rate (5.79 ± 2.78%/min) and 
5-min postheparin lipoprotein lipase activity (40.2 ± 23 ~-tEq fatty acid (FA)/liter/ 
min). The patients with a deficiency of debranching enzyme showed a significantly 
diminished triglyceride elimination rate (4.84 ± 1.61 %/min) whereas the S~min 
postheparin lipoprotein lipase activities did not significantly differ from the control 
values (49.6 ± 27.7 ~-tEq FA/liter/min). 
The patients with a deficiency of the phosphorylase sy~tem showed neither a 
significantly diminished triglyceride elimination rate (7.34 ± 2.65%/min) nor a 
diminished 5-min postheparin lipoprotein lipase activity (61.7 ± 30.1 ~-tEq FA/liter/ 
min). 
Triglyceride elimination rates were correlated positively with plasma lipoprotein 
lipase activities (r = 0.55, P < 0.05). 
Sj!r:wlation 
The dietary treatment of hyperlipidemia in hepatic glycogenosis might be based on 
the outcome of the intravenous fat tolerance test, a low fat clearance being an indica-
tion for a low fat, high carbohydrate diet, a normal fat tolerance for a high fat, low 
carbohydrate diet. 
Introduction 
Little is known about the causes of hyperlipidemia in 
patients with glycogen storage disease (GSD) [4, 5, 8]. 
The highest lipid levels are found in patients with a 
glucose 6-phosphatase deficiency. They have the high-
est fatty acid cholesterol ratios am\ sometimes even a 
pre-p-band on the electropheretograms. De novo fatty 
acid synthetizing activity from citrate is high in liver 
biopsies of these patients [7]. The pathogenesis of the 
hypertriglyceridemia in patients with a glucose G-phos-
phatase deficiency is presumed to be as follows: in the 
fasting state, conversion of glucose 6-phosphate to glu-
cose is blocked, so that glycogen can only be degraded 
to pyruvate through the glycolytic pathway. Part of 
the excess pyruvate is converted into lactate, another 
part into acetyl-CoA, <~nd thence into fatty acids, pre-
dominantly palmitate [4, 12]-
Hyperlipidemia is l.~~s striking in children with a 
deficiency of debranch.ng enzyme or of the phospho-
rylase system. In the : tlter deficiencies, the hyperlipi-
demia is characterized '.1y a dense p-lipoprotein band, 
no pre-{3-lipopmtein I ,1od being present on the elec-
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tropheretograms; the glycolysis is enhanced postpran-
dially, which leads to an increased lactate production 
and an increased liponeogenesis [4]. 
Although enhanced lipid production in the liver 
probably plays a causative role in the pathogenesis of 
GSD hyperlipidemia, it may not be the only factor. A 
pathologically low trigl-yceride clearance rate might 
also be an important factor. By measuring the triglyc-
eride elimination rate and the serum postheparin lipo-
protein lipase activity, we tried to gain more insight 
into the apparently complex causes of the hyperlipide-
mia. 
Materials and Methods 
The study comprised seven patients with a glucose 6-
phosphatase deficiency, seven patients with a de-
branching enzyme deficiency, and six patients with a 
deficiency of the phosphorylase system. Enzymatic 
studies had confirmed the diagnosis in all patients 
(Tables I-III). Ten patients without hyperlipidemia 
in whom an intravenous fat tolerance test had been 
performed served as control subjects (Table IV). They 
all had a normal nutritional status. Informed consent 
was obtained in each case. 
An intravenous fat tolerance test was performed in 
all GSD patients and control subjects. Heparin-re-
leased plasma lipoprotein lipase (LPL) activity was 
measured in most GSD patients and in some control 
subjects. Both tests were performed on consecutive 
days. The patients and the control subjects did not 
fast before the tests in order to prevent hypoglycemia 
in the patients. The meals during the 12-hr period 
before each test did not contain fat. The last meal was 
always given 2 hr before the test. The diet in the 2 
weeks preceding the tests contained about 25% of total 
calories at fat, mainly polyunsaturated, for all pa-
tients. 
The intravenous fat tolerance test [2] was carried 
out according to the method of Carlson and ROssner 
[3). For all tests, a 20% Intralipid emulsion [15] was 
administered intravenously in a dose of 0.1 g/kg body 
wt. Capillary blood samples were collected every 5 
min. The lntralipid concentration was determined by 
nephelometry. For each disappearance curve a mini-
mum of four consecutive points was used. The loga-
rithms of the Intralipid concentrations were plotted 
against time. Straight lines were obtained from which 
the correlation coefficients were calculated. 
The LPL activities were measured after the intrave-
nous injection of 100 U heparin/kg body wt in 5- and 
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40-min blood samples in most GSD patients, but in 5-
min blood samples only in most control subjects. As 
we concur with ROssner et al. [13] that the 5-min 
postheparin LPL activity probably gives more infor-
mation about fat elimination than the 40-min value, 
we have chosen the 5-min value as representative of 
LPL activity. The LPL activity was determined by the 
method of Kelly [11] as modified by Jansen and Hiils· 
mann [9]. The following minor modifications were 
introduced: the incubation mixture consisted of 1.1 ml 
Intralipid emulsion containing approximately 3.5 p.Ci 
( 14 C)trioleate, 3.0 ml human plasma freed of 13-lipopro-
teins as described by Jansen and Htilsmann [9], 6.0 ml 
10% solution of bovine albumin in 0.2 M Tris buffer 
pH 8.5, and 1.9 ml 0.2 Tris buffer, pH 8.5. This 
mixture was kept at 37° for 40 min. After this pretreat-
ment, 0.8 ml incubation medium was mixed with 0.2 
ml plasma to be investigated. The incubation time was 
35min. 
Results 
/ntralipid Elimination Constant in Patients and Con-
trol St~bjec/s 
The Intralipid elimination constants of the patients 
with a glucose 6-phosphatase deficiency and of the 
patients with a debranching enzyme deficiency were 
significantly lower than those of the control patients 
(P < 0.05). For the patients with a deficiency of the 
phosphorylase system, the difference was not signifi-
cant (Tables I-V). 
Heparin-released LPL Activity in Patients and Con-
trol Subjects 
The heparin-released LPL activity was higher in the 
5-min sample than in the 40-min sample in the major-
ity of GSD patients. Three out of six glucose 6-phos-
phatase-deficient patients, and one out of four de-
branching enzyme-deficient patients, however, showed 
5-min activities lower than the 40-min activities. Most 
patients with a glucose 6-phosphatase deficiency 
showed lower 5-min LPL activities as compared with 
the control subjects, the difference between both 
groups being significant (P < 0.05). Some patients 
with a deficiency of debranching enzyme or a defi-
ciency of the phosphorylase system showed decreased 
LPL activities as well, but the LPL activities of the 
latter two groups as a whole did not differ significantly 
from the LPL activities of the control subjects (Tables 
1-V). 
Tab!~[. Data for s~\"en pati~nts with a glu~os~ 6-phosphatase deficieney 1 
~~~~~~~~~~~~ 
Posthep&rin LPL aetivity, Glucose 6-pbo,ph•ta .. 
Ca« So< A~e, yr Cholesterol, Triglyceride•, "'· o/,/ ,.Eq FA/liter/min in liver, nmole! mmol/liter mmol/liter 
------·-
"------"-
cc F 4.2 4.87 J.l2 
2. ss 
" 
:l.;, :.l .. 'i:l 1.75 
3. AR F 2.') 5.78 8.55 
4. AW F 2!1.2 !.1.02 13.00 
'" 
DS 
" 
l.!J 3.86 0. 7!! 
6 MB F 3.2 3.:lS 2.47 
7. RS 
" 
:l.o 6.30 2.56 
m 5.24 4.60 
2.29 4.46 
'F: female; M: male; LPL; lipoprotein lipase: F.\: fatty acid. 
' lntra\lpid elimination constant [3;. 
'Normal range 24.0-93.0. 
min> P;/min/"'11 protoin Smin ~0 min 
2.46 0.9936 13.0 5 6 0.0 
5.20 0.994-7 36.7 49.1 1.0 
3.00 O.<J990 35.8 24.5 0.9 
6.22 0.9973 24.0 28.1 0.0 
4.YO 0.9933 30.6 38.8 1.7 
!J.OO 0.9955 83.1 5.1 
Y. 7!J 0.9950 57.3 19.3 l.B 
6' 
5. 7') <0.2 
2. 78 23.0 
Table If. Data for sev~n patients with a debranching enzyme deficiency 1 
Chol .. terol, Triglycerides, !.;;,%/ P;'cy:h:~riFnA71~~,j;!\~- B:~:en~~::u~~~~;;. (;':,\\ c ... 
'" 
Age, yr mmol/liter mmol/liter dutrin/min/nl! pr<~toin 
Smin ~0 min Leueoeyt .. Liver 
I. PL F 15.2 6. 75 200 4.30 0.98Y7 98.0 68.2 0.00 
2 DL F 14.0 5.50 2.27 3.75 0.9974 60.9 4i .9 0.00 
3. AD F ll . !) 7.05 0.9855 51.4 0.00 0.00 
4 JK F 7.4 3. 73 0.95 5.86 0.9(!50 0.09 0.13 
5. JB F 5.8 404 2.9J 3.98 0.9929 38.2 0.00 
'" 
JZ F 12.0 6.86 4.09 6.36 0.9760 22.6 37.7 0.00 0.20 
7. JK 
" 
1.2 660 5.43 2.58 0. !J'JOti 26.4 !8.0 0.2C' 0.65' 
Normal range 0.33-l .80 0.5-2.3 
" 
6 6 6 l4 6 
m 5.58 2.94 4.84 49.6 
l.«l 1.60 1.61 27.7 
'F: f~mak; M: mal"; LPL: lipoprot~in lipase; F.\: fatty acid. 
t The assay was modified and performed at a higher crmcentration of limit dextrin (normal rang~ for ].,ucocytes 2.07-5.0+ (o "" 8), for 
liver2.13-9.09 (n"" 3). 
Levels of Triglyceride and Cholesterol in Blood in 
Patients and Control Subjects 
The triglyceride levels were significantly higher (P 
< 0.05) in the three patient groups as compared with 
the control subjects. The cholesterol values were sig· 
nificamly increased in the patients with a de!Jranching 
enzyme deficiency as compared with the control sub-
jects (Tables 1-V). 
Correlations of lntralipid Elimination Constants, LPL 
Activities, and Levels of Triglyceride in Plnsma 
of CSD Patients 
The Intralipid elimination constants and the LPL 
activities 5 min after heparin injection showed a sig-
nificant positive correlation (r = 0.55, P < 0.05, Fig. 
1). The Intralipid elimination constants and the 
plasma triglycerides, on the one hand (Fig. 2), and the 
LPL activities 5 min after heparin injection and the 
plasma triglyceride;, on the other hand (Fig. 3), were 
not significantly correlated. 
Discussion 
Much work has been done to find the cause of the 
deficient LPL activity in disturbances of the niglycer-
ide elimination system. The synthesis of LPL activity 
in adipose tissue taken from rats appears to be under 
hormonal control. Insulin has a positive effect, 
whereas catecholamines, glucagon, growth-stimulating 
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Table III. Data for six pati~nts with a d~fi.ciency of phosphorylase systern1 
COolos· Tr"•giYC<r· Postbeparin LPL activity. Phospborylase in leuc<>cytes. (;~~i~~~rr.l~:~. b (<COl, ide•. ~.;;,,_%/ ~EQ FA!Jiter/rmn nmol/min/mgpr<>t<in Case' Sex Age. yr rnmoll mmol/ mm cyte•, U activated/ 
liter liter .\min 40 min 4MF +AMP min/mg protein 
J. MT M 2.8 5.37 3.69 3.66 O.YY24 13.9 5 6 6.1 0.29 
2 OT M 1.4 5.30 2.87 5.50 0.9957 45.8 21.6 7.9 9.8 0.65 
3 JH M 7 .I 4.84 1.08 11.1(.> 0.9915 72.9 43.9 3.0 14.0 0.(18 
4 WT M 9.1 5.67 0.91 6.50 0.9860 84.7 48.1 0.08 
5. Jl M 6.0 4.26 1.87 8.90 0.9435 CJ8.0 37.2 3 0 20.0 0.00 
6. .HR M 7.2 6.24 0.83 8.3') 0.9862 Yl."3 20.2 5 0 21.0 0.02 
Normal range 15.8--47.9 18.0-50.1 0.37-0.65 
6 !6 
5.28 !.87 7.34 61 .7 
0.68 1.17 2.65 30.1 
'~I· mal~; LPL; lipoprotein lipa.>e; FA: fany acid. 
1 Palimlo J and 2 {brothcn} are pho;;phorylase deficient; phosphoryl as~ activity in the liver 0.0 and 0.0 nmo)esjminjmg protein, respec-
tively; palimtt 3-6 are phosphorylase b kinase def•cient; liver biopsy, performed in one patient (paliml 4), confirmed the diagnosis. 
Table IV. Data for lO control children' 
_ ___.:. _____ " __ ,__ _ 
Case Sox A~e. yr C~olosterol, mmol/liter 
Trig]ycerides. 
mrnoi1 Htor 
Po•thoparin LPL octivity,,..eq 
FA/liter/min , 
·-----
I. SE 
" 
3.1 
2. KJ F 1.5 
3 FJ F 8.0 
4 A}) F 4.2 
5. PC F 7.8 
6. o.w 61 4.2 
7. vc F 12.3 
8. vs F 8.1 
9. oc 
" 
2.2 
" 
MR 
" 
9.9 
4.57 
4.38 
5.10 
4.60 
5.01 
4.35 
3.50 
4.23 
5.20 
4.54 
0.52 
0.45 
0.52 
0.63 
0.93 
o. 70 
0.68 
0.86 
0.60 
0.80 
0.68 
0.15 
11.59 0.9894 
8.01 0.9958 
7.83 0.9791 
5.70 0.9900 
7.06 0.9981 
8.66 0.9990 
8.86 0.9896 
7 .II 0.9966 
10.10 0.9320 
9.20 0.9970 
10 
8.39 
!.66 
5 min 40 min 
72.4 67.4 
102.7 
42.5 
113.7 
4 
82.8 
32.4 
-----c--··----· 
'1\f: male; F: female; LPL: lipoprotein lipase; F.\: fatty acid 
hormone, and adrenocorticotropic hormone have been 
shown to have a negative effect on the LPL activity 
[I OJ. Further studies on the factors regulating LPL ac-
tivity were described in 1966 by Salamon and' Robin· 
son [14], who incubated intact epidymal fat bodies 
taken from rats that had been starved for 48 hr and in 
which the activity of LPL was low, in a medium de-
signed to promote enzyme activity. They found that, 
as expected, the LPL activity increased to a level char-
acteristic of the tissue of intact animals in the fed 
Mate. Glucose and insulin were important constituents 
of the incubatiorl medium, insofar as the omission of 
either markedly reduced the increase in emyme activ-
ity. Therefore, LPL synthesis in patients with a glu-
cose 6-phosphatase deficiency may l>e impaired by the 
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low levels of glucose and insulin in blood [6]. As for 
our patients with this enzyme defect, not only LPL 
activities, but also lntralipid clearance rates were sig-
nificantly reduced as compared with the control pa-
tients. Our patients deficient in debranching enzyme 
or the phosphorylase system, however, in whom symp-
toms of hypoglycemia are mild and rare, showed LPL 
activities that did not differ significantly from those of 
the control patients. Nevertheless, the patients with a 
del>ranching enzyme deficiency showed Intralipid 
clearance rate> significantly lower than the control sub-
jects. "\Ve have no explanation for the discrepancy be-
tween the normal LPL activity and decreased fat elim-
ination in debranching enzyme-deficient patients. 
Thus, we may explain the hyperlipidemia of GSD 
Table V, Intravenous fat tolerance test (IVFTT) and 5-min posthepa•in lipopi"Otein lipase (LPL) in glycogen storage disease patienu 
and control subjecu 
Gluco>< 6-phos-
phataoe deficiency 
m 
2.46 
5.20 
3.00 
6.22 
4.9<3 
9.00 
9. 79 
5. 79 
2. 78 
'FA: fatty add. 
" z ~10 
8 
' z ~ 6 I 
0 
w 4 
' 
!\"FIT K,, %/min 
Debranching tO· 
zyme deficiency 
•• 
4.30 
3.75 
7.05 
5.86 
3.98 
• 
6.36 
2.58 
4,84 
1.61 
Phosphorylase 
deficiency Control subjects 
3.66 
5.50 
ll.lO 
6.50 
8.90 
8.39 
7.34 
2.65 
• 
~ PAT!ENTS 
e CONTROLS 
11.59 
8.01 
7.83 
5. 70 
7.06 
8.66 
8.66 
7.ll 
10.10 
9.20 
10 
8.39 
1.66 
20 40 60 80 100 120 140 
LPL ACTIVITY !Jttq FA/tfmio 
Fig. 1. Relation between lipoprotein lipase (LPL) activities mea-
sured 5 min after the intravenous injection of 100 U heparin/kg 
body WI and lntralipid elimination constants of patients with 
glycogen storage disease and control subjects. FA; fatty acid. 
patients as follows. The hypertriglyceridemia of pa-
tients with a glucose 6-phosphatase deficiency is due to 
a combination of a decreased triglyceride elimination 
rate and increased endogenous liponeogenesis [7, 12], 
the former factor being the more important one. We 
did, indeed, observe that a high fat diet worsens the 
hypertriglyceridemia, which thus seems to be fat-in-
duced (data not shown). The hyperlipidemia of pa-
tients with a deficiency of debranching enzyme or the 
phosphorylase system, however, is mainly caused by 
5-min posthepnrin LPL, ~eq FA1/Iiter/min 
Glucose 6-phos- Debanching en- Phosphoryla.e Control>ubject• phatase deficiency •yme de6ciency defidency 
13.0 98.0 13.9 
36.7 60.9 45.8 72.4 
35.8 51.4 72.9 102.7 
24.0 84.7 
30.8 38.2 98.0 42.5 
83.1 22.6 55.3 
57.3 26.4 
I 13.7 
6 4 
4D.2 49.6 6\.7 82.8 
23.0 27.7 30.1 32.4 
carbohydrate-induced liponeogenesis [4], as impaired 
fat elimination probably plays a significant role in 
debranching enzyme deficiency only. {Discrepant re-
sults of fat elimination tests in debranching enzyme 
deficients do not permit a firm conclusion.) The die-
tary implications shoUld be that for children deficient 
' •• .. ~ 
.. 
. . 
. . 
• 
.• 
ll GSD PATIENTS 
•CONTROLS 
·' 
24 81012 
INTFIALIPID ELIMINATION CONSTANT(Y.mln) 
Fig. 2. Relation between Intralipid ~limination wn~tant~ and 
levd5 of triglyceride (TG) in plasma (log values) of patients with 
glycogen storage disease (GSD) and control subjects. 
31 
' 
' a 
.6 
.• 
•• 
• 
• 
• 
• 
x G S 0 PATIENTS 
<!I CONTROLS 
• 
• 
20 40 so so roo 120 
LPL ACTIVITY flflQ/Ijmin 
Fig. 3. Relation between lipoprotein lipase (LPl.) a~th·ities mea· 
sured 5 min after the intravenous injection oE 100 U heparin/kg 
body wt and levels of triglyceride (TG) in plasma (log values) of 
patients with glycogen storage disease (GSD) and control subjects. 
in glucose 6-phosphatase, a low fat, high carbohydrate 
diet is indicated, whereas for children with phospho-
rylase deficiency and possibly also those with a de-
branching enzyme deficiency, carbohydrate rather than 
fat restriction is indicated. 
Summary 
The hyperlipidemia of 20 patients with GSD was stud-
ied by the intravenous lntralipid tolerance test and 
the determination of the plasma postheparin lipopro-
tein lipase activity. Patients with a glucose 6-phospha· 
tase deficiency were characterized by abnormally low 
results for both tests as compared with control chil-
dren. Patients with a deficiency of debranching enzyme 
showed a decreased lntralipid elimination constant, 
whereas the LPL activities did not significantly differ 
from control values. Patients with a deficiency of the 
phosphorylase system showed normal results for both 
tests. 
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A positive correlation was found between the Intra-
lipid elimination constant and the postheparin LPL 
activity in the patients. 
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Chapter III (2) 
Plasma triglyceride clearing in obese children 1 ,2 
P.P. Forget 3 , J. Fernandes 4 , and P. Haverkamp Begemann 5 
ABSTRACT. In 13 obese children plasma 
triglyceride concentrations were found to 
be significantly elevated, while plasma 
cholesterol concentrations were normal. 
In the hypertriglyceridemic obese 
children, the plasma triglyceride removal, 
measured by the intravenous fat tolerance 
test, was significantly reduced. A few 
patients showed an increased triglyceride 
production. These abnormalities reverted 
to normal in 8 patients retested after 
weight loss. Plasma postheparin lipo-
protein lipase activity was found to be 
increased and significantly related to the 
degree of obesity. As to carbohydrate 
metabolism, a decreased glucose tolerance 
and hyperinsulinemia were found. Hyper-
insulinemia reverted to normal during 
dietary restriction, glucose intolerance 
did not. 
Prospective and retrospective studies have 
shown the importance of childhood 
obesity as a forerunner of adult obesity 
(1, 2, 3). Mortality data from life insur-
ance studies clearly demonstrate in-
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creased death rates among obese adults 
(4). Disturbances of carbohydrate and 
lipid metabolism can, among other 
factors, account for this increased mortal-
ity rate (4). Whereas carbohydrate 
metabolism has been fairly extensively 
studied in obese children (5, 6), sur-
prisingly few studies of plasma lipids in 
childhood obesity are available. Plasma 
triglyceride and cholesterol levels in this 
condition have been reported to be ele-
vated by some authors (7) and normal by 
others (8). The present investigation 
aimed primarily at studying plasma tri-
glyceride clearing in a small group of 
obese children before and during weight 
reduction. As · disturbances of plasma 
lipids in obesity often are related to 
disturbances of carbohydrate metabolism 
(9) the latter was also investigated. 
Patients and methods 
Patients 
13 obese children (7 females and 6 males, 
ages ranging from 7 to 15 years) were 
studied. Relative weight has been used as 
a rough·indicator of the degree of obesity 
(Table 1). It was calculated by dividing a 
patient's weight by his ideal weight for 
length taken from growth charts of 
normal Dutch children (10). Obesity was 
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considered to be present when relative 
weight exceeded 1.2 (II). 3 Children had 
become obese before, the remainder after 
the age of 3 years. In all but one child 
obesity was present in first degree rela-
tives. Age-matched children admitted to 
hospital for minor surgical problems were 
used as controls for plasma lipid values. 
Bloodsamples were always taken in the 
fasting state (12-14 hours). Control values 
for the intravenous fat tolerance test 
(IVFTT) were taken from a previous 
study (12). Control values for plasma 
postheparin lipoprotein lipase (PHLPL) 
activity were obtained from young 
heal thy adults as control values for 
children were unavailable. 
Experimental design 
A detailed dietary history was obtained 
by a trained dietitian. Caloric content and 
composition of the diet was calculated 
(Table 2). During the short hospital 
admission which followed, the following 
investigations were performed. 
On the morning of admission and 2 hours 
after a small standard fatless carbo-
hydrate breakfast, bloodsamples were 
taken for the determination of basal 
plasma triglyceride and cholesterol con-
centration. Subsequently an !VFTT was 
performed as described previously (12). 
In short, 0.1 g/kg ideal body weight plus 
0.05 g/kg excess weight (13) of lntralipid 
20% (Vitrum, Stockholm) was injected 
i.v. within one minute. In the following 
half hour plasma Intralipid concen-
trations were determined by nephelo-
metry at 5, 10, 15, 20, 25, and 
30 minutes respectively. From the expo-
nential Intralipid elimination curve 
obtained, the elimination constant was 
calculated and expressed as % removal/ 
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minute. Relative plasma triglyceride 
production rate was estimated by multi-
plying the IVFTT value by the plasma 
triglyceride concen !ration (mmo1es/1 
plasma) as suggested by Rossner et al. 
(14). Results were expressed as mmoles/1 
plasma/minute. One hour after starting 
the IVFTT the plasma PHLPL activity 
was measured in bloodsamples taken 5 
and 40 minutes after the i.v. injection of 
100 U heparin/kg body weight. Plasma 
PHLPL activity was determined as 
described previously (12). On the second 
morning of hospital stay, after a fasting 
period of 12-14 hours bloodsamples were 
taken for the determination of basal free 
fatty acids (FFA), triglyceride, glucose 
and insulin levels. Then, an oral glucose 
tolerance test was performed. Capillary 
bloodsamples for glucose and insulin 
determinations were taken 30, 60, 90, 
120, and 150 minutes after an oral 
glucose load of 1. 75 g/kg ideal body 
weight. In the afternoon, the patients 
were sent home on a hypocaloric diet 
consisting of approximately 60% of the 
previous caloric intake (Table 2). Caloric 
distribution was as follows: Protein ± 
30% of total calories, fat ± 25% of total 
calories, carbohydrate ± 45% of total 
calories. After a diet period varying from 
6 weeks to 5 months, 8 patients were 
readmitted to hospital. The weight loss 
varied from 1-9 kg. The same investiga-
tions as described above were repeated. 
For clinical characteristics see Table 1. 
Ana/y tical methods 
Blood glucose was determined by the 
glucose oxidase method (15). Serum tri-
glycerides concentrations were deter-
mined according to the method of 
Schmidt and von Dahl (16). Serum 
cholesterol concentrations were deter-
mined according to the method of Carr 
and Drekter (17). For the determination 
of serum FFA we used the extraction 
method described by Royer ( 18) followed 
by titrimetric measurement according to 
Korovina (19). Plasma insulin levels were 
determined according to the method of 
Maingay (20) with modifications accor-
ding to Herbert et al. (21). 
Statistical methods 
The two-sample test of Wilcoxon, based 
on rank-order, was used for calculating 
the significance of differences between 
means of obese and control patients. 
Paired data analysis was performed when 
comparing pre- and post-weight reduction 
results. Simple correlation coefficients 
were calculated by Kendall's distribution 
free test. Regression analysis was per-
formed for calculating the relationshlp 
between the logarithm of plasma triglyce-
ride concentration and the Intralipid 
elimination constant. 
Table 1 Clinical and laboratory data in 13 obese children before and during (8 patients) weight reduction 1 
Ca~ 
'" 
Weight Height Relative Fasting Fasting Fasting K1 J %/min Rdative Postheparin LPL t 
'"' 
(kg) (om) weightl cholesterol FFA I triglyceride triglyceride activity 1 
••• concen· concen· concen· production /.leq FA II/ min (yr) tration tration !ration rate 5 min 40 min 
mmoles/ maeq/liter mmoles/ mmo)es/1 
liter liter plasma/min 
8 A 8 8 A. 8 A. 8 A. 8 A. 8 A. B. A. 8. A 8 A 
' 
[.". )9 )2 
'" 
1.69 1.23 4.15 4.30 0.66 1.20 0.52 0.38 9.0 8.9 4.68 3.38 181.8 63.9 232.2 142.1 
l F. 
" 
40 ,., 1.48 1.14 5.10 3.84 1.25 0.83 0.30 4 6 1U 3.81 3.99 115.2 61.9 249.8 159.4 
) F. 
" " 
49 
'" 
1.40 1.20 6.07 6.60 0.62 1.46 0.53 8.9 1.0 12.99 3.71 46.6 50.1 163.8 126.6 
4 M. 
" " 
60 
'" 
1.75 1.60 4.3\ 4.00 0.85 1.04 1.11 0.45 4) 8.1 4.77 3.92 89.3 100.7 110.7 192.6 
F. 
" 
4) 40 
'" 
1.43 1.21 5.26 5.02 0.97 0.75 0.97 0.67 l' 1) 3.68 4.89 53.6 94.8 56.5 138.1 
M. 12 
" 
60 , .. 1.75 1.64 5.64 4.90 0.97 0.84 2.10 1.21 )) 6.3 6.93 7.62 105.1 182.5 198.1 209.1 
F. 1 42 31 
'" 
1.50 1.32 5.32 4.05 1.18 0.96 0.51 6.9 9 9 6.62 5.05 109.8 115.5 222.6 150.6 
M. 
" 
, 48 
'" 
1.48 1.34 5.97 4.47 1.12 0.72 0.34 0.42 11.5 10.8 3.91 4.93 103.0 84.2 167.0 104.1 
F. 
" " 
, .. 1.58 4.71 1.05 0.50 11.0 5.50 115.7 170.0 
" 
F. 
" 
6J 
"' 
2.33 5.77 3.47 4.6 15.96 116.4 235.7 
" 
M. ,. 60 
'" 
1.46 4.85 0.69 1.05 4.6 4.83 63.3 109.5 
" 
M. 
" 
90 
'" 
1.60 5.28 2.12 6.9 14.62 69.5 167.6 
" 
M, 13
" '" 
1.54 6.50 0.73 1.76 •. o 7.04 
Mean 5.31 4.64 0.87 0.94 1.32 0.55 64 9.0 7.33 4.68 97.4 94.15 173.6 152.8 
SD 0.67 0.89 0.21 0.20 0.86 0.28 2.8 ll 4.29 1.34 36.7 41.92 58.8 34.2 
Controls 
Mean 5.17 0.94 0.53 8.) 5.59 51.4 129.3 
S.D. 0.77 0.30 0.12 L6 1.38 
" " (19) (13) (22) (10) (9) 
'" '" 
LPL: lipoprotein lipase; FF A: Free fatty acids: FA: fatty acid; B; before weight reduction: 
A: after weight reduction. 
Patient's weight di\<ided by ideal weight (see text) 
!ntralipid elimination constant {see text) 
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Table 2 Dietary history of obese patients 
Case Sex Age,yr Weight Daily caloric intake 
kg 
total 
1 F 7 39 1500 
2 F 8 49 2000 
3 F 11 56 1600 
4 M 13 65 1800 
5 F 8 43 1900 
6 M 12 61 3100 
7 F 7 42 1900 
8 M 11 52 1900 
11 M 14 60 2600 
12 M 15 90 3100 
13 M 13 71 2500 
1 See under patients and methods. 
Results 
Plasma triglyceride, cholesterol and FFA 
concentrations in obese patients before 
and during diet therapy 
When compared to values obtained in 
age-matched control children, the plasma 
triglyceride concentration of obese 
patients were initially significantly in~ 
creased (p < 0.001, Table 1). During diet 
therapy plasma triglyceride levels of 
obese patients decreased to normal values 
(Fig. 1). No significant changes of plasma 
cholesterol and FFA concentrations 
occurred (Table 1). 
Fig. I 
Plasma triglyceride concentrations (means ± 
SEM) 
A. 22 control patients 
B. 8 obese patients 
C. the same 8 obese patients during diet ther~ 
apy 
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per kg per kg 
body ideal 
weight body 
weight1 
39 66 
41 61 
29 40 
28 48 
44 64 
51 90 
45 68 
36 54 
43 63 
34 55 
35 54 
1.5 
. 
-" 0 
E 
E 
g 
~ 
" 
"' ~ ~
~ 
0.5 
Caloric distribution 
% 
CHO Fat Protein 
52 28 19 
44 44 12 
56 23 22 
47 35 17 
44 39 17 
47 41 12 
47 41 12 
54 33 13 
55 35 10 
39 43 17 
51 32 17 
A:Controls 
B:Obese 
C:Obese on diet 
l 
P<0.01 
P<0.001 I I 
A B c 
lntralipid elimination constant in obese 
patients before and during diet therapy 
I 0 out of 13 obese children were found 
to have fasting triglyceride concentrations 
above the range of our control children 
(higher than mean + 2s of control 
children). The mean lntralipid elimina· 
tion constants of these 10 obese hypertri-
glyceridemic children was significantly 
lower than that of control children 
(p < 0.002). 8 Children could be retested 
after weight reduction. 4 Of these showed 
initially decreased lntralipid elimination 
constants. All 8 children showed normal 
results when retested (Table 1). 
Relative triglyceride production rate in 
obese patients before and during diet 
therapy 
3 Out of the 13 obese patients showed 
triglyceride production rates exceeding 
the range found in control children 
(Table I). Of these 3 children, only I 
could be retested during diet therapy and 
showed then a normal result (Table !). 
Normal triglyceride production rates were 
found in the other 7 children retested 
during diet therapy (Table 1). 
Postheparin lipoprotein lipase activity of 
obese patients before and during diet 
therapy 
When compared to values obtained in 7 
young adults, a significant elevation of 
5 minutes PHLPL activity was found in 
obese patients initially (p < 0.01). No 
significant elevation of 40 minutes 
PHLPL activity was found (for values see 
Table 1). The slight decreases of 5 and 
40 minutes PHLPL activities which oc-
curred during diet therapy were not sig-
nificant. 
Plasma triglyceride concentration and 
lntralipid elimination constant 
The relationship between the logarithm 
of plasma triglyceride levels and the 
Intralipid elimination constant is shown 
in Fig. 2. A significant negative correla-
tion was present in the obese patients 
before diet therapy (r ~ 0.66, p < 0.02) 
and in the 8 patients retested after weight 
reduction (r ~ 0.80, p < 0.02). 
.6 
.6 
.4 
.3 
.2 
Fig. 2 
e Controls 
CJ Obese 
u Obese on diet 
2 s ro 14 re 
INTRALIPID ELIMINATION CONSTANT(%/m!n) 
RelationShip between plasma triglyceride con-
centration (log-value) and the Intralipid elim-
ination constant in 9 control patients, in 13 
obese patients before and 8 obese patients after 
weight reduction (Straight lines connect indi-
vidual patients before and after values). 
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Plasma triglyceride concentration and 
postheparin lipoprotein lipase activity 
No correlation was found between plasma 
triglyceride concentration on the one 
hand and 5 or 40 minutes PHLPL activity 
on the other. 
Oral glucose tolerance test in obese 
patients before and during diet therapy 
A diminished glucose tolerance was found 
in obese patients both before and during 
diet therapy (Fig. 3). Control values were 
taken from Paulsen et al. (6). Only the 
fasting values decreased significantly 
during diet therapy (Fig. 3). 
Plasma insulin levels before and during 
oral glucose tolerance tests in obese 
patients before and during diet therapy 
Elevated insulin values were present 
initially in obese patients (Fig. 3). The 
significant decrease to normal values (6) 
during diet therapy is shown in Fig. 3. 
The insulin area under the insulin curve 
showed a significant decrease from 337 ± 
70 (SEM) to 166 ± 20 (p < 0.05). 
Correlation between fasting and stimu~ 
lated insulin release and other metabolic 
parameters 
No significant correlation was found 
~ 10 _100 
E 
E 
UJ gJ 8 
g 
.... 
"' 
6 
4 
! 
P<0.02 
2 N.S. 
o-eObese 
...... Obese on diet 
. ·····! 
N.S. N.S. 
NS. NS. 
~ 
z 
~ 80 
;;:: 
60 
40 
20 
-obese 
..... Obese on diet 
!··. I \~-+-+1 
f N.S. P<0.05 N.S. 
0 O N.S. P<0.02 p<0.02 
0 30 60 90 120 150 min 
Fig. 3 
Glucose and insulin curves during oral glucose 
tolerance tests in 8 obese patients before 
(e-----o) and during (e----e) weight reduction 
(data are given as means± SEM). 
N.S.: difference non significant 
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0 30 60 90 120 150 min 
between fasting insulin levels, peak 
insulin levels or area under the insulin 
curve on the one hand and glucose toler~ 
ance (peak glucose, 2 hours glucose, area 
under the glucose cutve), triglyceride 
bloodlevels, triglyceride production rate, 
lntralipid elimination constant and 
PHLPL activities on the other hand. 
Correlations between relative weight as a 
measure of obesity and metabolic data 
A significant positive correlation was 
found between relative weight and 
5 minutes PHLPL activity in the 12 obese 
patients before diet therapy (p < 0.05, 
Fig. 4 ). This correlation was found once 
more in the 8 patients retested after 
weight loss (p < 0.05), Fig. 5). No signifi· 
cant correlation could be found between 
relative weight and any of the other meta-
bolic parameters measured. 
Discussion 
Before discussing the results obtained one 
should point out that when retested after 
weight loss our patients were still on diet 
therapy. Consequently, when looking at 
the metabolic effects of diet therapy we 
cannot dissociate between the effects of 
the diet itself and those of weight loss. As 
shown in Table 2 dietary history revealed 
the caloric intake of most of our obese 
patients to be normal. This is in agree· 
ment with findings of others (22, 23) and 
supports the idea that obesity is more a 
problem of energy expenditure than of 
energy intake. 
The significant increase of plasma tri-
glyceride levels found in our obese 
children is in agreement with the data of 
Aikawa M. (7), although, contrary to the 
findings of this last author, plasma 
cholesterol levels were found to be 
normal in our patients. The findings of 
normal fasting free fatty acid levels in our 
obese children is in agreement with litter-
ature data ( 6). 
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Fig. 4 
Relationship between relative weight and 
plasma 5 min PHLPL activity in 12 obese 
patients before diet therapy 
" 
.b 
Fig. 5 
Relationship between relative weight and 
plasma 5 min PHLPL activity in 8 obese 
patients after weight loss. 
Plasma triglyceride removal (measured by 
the IVFTT) was significantly decreased in 
hypertriglyceridemic obese patients. 
Plasma triglyceride production rates were 
calculated (see methods) and appeared to 
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* increased in some 
be * patients (3 out of 13). These results 
paint to a defective removal mechanism 
as the main causative factor of hypertri· 
glyceridemia in obese children, elevated 
triglyceride production rates playing a 
contributory role in some children. 
Hypertriglyceridemia associated with a 
decreased Intralipid removal constant has 
been reported in obese adults (14). 
Different authors using the radio-glycerol 
technique for measuring plasma tri-
glyceride turnover reported divergent 
results. Some investigators found tri· 
glyceride turnover to be elevated in obese 
patients (9) while others reported no 
increase and pointed to a defective 
plasma triglyceride removal as the prob· 
able cause of hypertriglyceridemia in 
these patients (24). We found a signifi-
cant negative correlation between plasma 
triglyceride levels and lntralipid elimina-
tion constants (Fig.2). This most probably 
reflects the close dependency of triglyce-
ride bloodlevels on removal efficiency 
in obese children. 
We found increased 5 minutes plasma 
postheparin LPL activities in our obese 
children when compared to values ob-
tained from 7 young healthy adults. 
Although such a comparison between the 
data of two different age groups can only 
be made vvith reservation, our results are 
supported by those of others who re-
ported elevated plasma PHLPL activities 
in adult obese patients (25). This is not 
very surprising as it is known that fat cell 
volume is increased in obese children (26) 
and that fat cell LPL content is positively 
correlated with fat cell volume in normal 
man (27). Thus, an increased body fat 
mass could lead to a higher LPL content 
of adipose tissue. The significant positive 
correlation found between relative weight 
(as a measure of obesity) and 5 minutes 
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postheparin LPL before (Fig. 4) and after 
weight loss (Fig. 5) seems to support this 
hypothesis. 
The finding in our patients of high plasma 
PHIPL activities associated with low 
IVFTT values could be explained as fol-
lows. In normal man only 13% of circu-
lating lntralipid is removed by adipose 
tissue (28). Consequently a normal to 
high lntralipid fractional removal in 
adipose tissue of our patients could be 
compatible with a low IVFTT value if 
other quantitatively more important 
removal sites were blocked. As in our 
patients plasma PHLPL activities were 
high and related to the degree of over-
weight (relative weight) we suggest that 
triglyceride removal in adipose tissue of 
obese children is increased above normal 
while removal at other extrahepatic sites 
is markedly decreased. This hypothesis is 
supported by the findings of Bjorntorp 
and Sjostrom who showed that large fat 
cells in vitro are metabolically more 
active than small fat cells (29) and conse-
quently that in obesity fat cell triglyce-
ride turnover is increased. The striking 
decrease of plasma insulin levels during 
the second oral glucose tolerance test 
(Fig. 3) has been frequently reported in 
adult obese patients after weight loss (30, 
9). While a low caloric, low carbohydrate 
diet could lower the insulin response to 
an oral glucose load, the same diet is 
known to result in glucose intolerance 
(31 ). Consequently, the persisting glucose 
intolerance we found, could be due to the 
fact that a preparatory diet, as advised by 
Conn (31 ), was not used in our patients 
before performing the second glucose 
tolerance test. 
We wish to thank Miss N. de Kart for her 
technical assistance and Miss. M. Mey· 
vogel for dietetic evaluation. 
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Chapter III ( 3) 
ENHANCEMENT OF FAT ELIMINATION DURING INTRAVENOUS 
FEEDING 
P. P. F. X. FORGET. J. FERNANDES ~nd P. HAVERKAMP BEGEMANN 
From the Departments ~~(Paediatrics, Sophitl Children's Hospital and Neonatal Unir, 
EraJintls Unh·eniry, Rotrerdwn, The Nl'lhalands 
ABSTRACT. Forget, P. P. F. X., Fernandes, J. and Haverkamp Begemann, P. (Depart-
ment of Paediatrics, Sophia Children's Hospital and Neonatal Unit, Erasmus University, 
Rotterdam, the Netherlands). Enhancement of fat utilization during prolonged intravenous 
feeding. Acta PaediatrScand, 63:750, 1974.-An 8-year-old girl with severe underweight 
caused by anorexia nervosa was treated with total intravenous nutrition for 4 weeks. 
During this period the lntralipid dose was stepwise increased, the doses of Yamin and 
glucuse were kept constant. The lntralipid dose was monitored by the determination of 
the serum Intralipid levels. The fat utilization was investigated by intravenous fat 
tolerance tests and the estimation of postheparin lipoprotein lipase activity of the plasma. 
The Intralipid elimination constant Increased from 7% to 22%/min, the postheparin 
lipoprotein lipase activity increased from 50 to 317 _ 1-1-Eq fatty acid/min/!. These data 
enabled us to increase the lntralipid dose from 3 g fat/kg/per day to 8 g fat/kg/per 
day, without an increase or the triglyceride blood levels. We may conclude that lipo-
protein lipase is an inducible enzyme. It is not clear which component of the hyper-
caloric intravenous regime causes this induction. 
KEY WORDS: Parenteral feeding, postheparin lipoprotein lipase, intravenous fat toler-
ance test 
Little is known about the utilization and 
tolerance of fat emulsions in paediatric pa-
tients. 
An Intralipid (Vitrum) dose of 4 g/kg 
body weight per day has been used by some 
authors with acute side effects (6) and by 
others without any toxic effects ( 1). In the 
former studies the daily dose was infused 
over a period of 6 hours, in the latter over 
a period of 24 hours. It is tempting to infer 
that a\:ute toxicity arises whenever the dose/ 
time ratio is too high leading to high Intra-
lipid blood levels. 
responsible for triglyceride elimination, be-
comes saturated. An [ntralipid dose which 
exceeds the maximal LPL clearing capacity 
is probably slowly eliminated by aspecific 
ways such as phagocytosis by RES cells 
and liver (6). The plasma Intralipid levels 
must therefore not exceed a critical concen-
tration of approximately 100 mg/100 mi. 
when LPL becomes saturated. 
It has been shown by Hallberg (4) that 
fat tolerance tests with high dosage yield 
elimination curves. which are biphasic. At 
the point where one phase passes into the 
other. lipoprotein lipase (LPL). the enzyme 
A era P~diatr Srand 63 
The lntralipid blood level depends on the 
one hand on the patient's clearing capacity 
for fat and on the other hand on the Intra-
lipid dose. 
Recently we had the opportunity to study 
a patient', who had to be fed parenterally 
for a prolonged period. By determining this 
patient's clearing capacity at frequent inter-
vals and by the daily investigation of Intra-
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Fig. !. Complete parenteral nutrition for 4 weeks in an 
8-year-old child. The diagram shows the amount of fat 
{20% Intra~pid), amino acids (Vamin) and glucose 
given. The changes in body weight, postheparin LPL. 
Intra~pid clearance rate and Intralipid serum concentra-
tion are also recorded. 
lipid blood levels, we tried to get some more 
insight in the mechanism of fat clearing dur-
ing parenteral feeding. 
MATERIAL AND METHODS 
The patient was an 8-year-old girl with a long history 
of anorexia. Her height was just under, her weight far 
below, the third percentile. No evidence of organic dis-
ease was found. In close cooperation with our psychi· 
atrists we decided to replace oral by parenteral feeding 
for 4 weeks. 
We administered lntralipid 20% (Vitrum). Yamin (Vit· 
rum) and glucose from separate bottles simultaneously. 
at a constant rate around the clock. Caloric intake was 
stepped up from 60 to 120 calories/kg/day (Fig. 1). 
Vitamins and minerals were given orally. 
The intravenous fat tolerance test (IVFTT) was car-
ried out according to Carlson & ROssner (2). For all 
tests a 20% lntralipid emulsion was administered intra-
venously in a dose of 0.1 g far{kg body weight. within 
one minute. Capillary blood samples were collected 
every 5 minutes for 30 minutes. The lntralipid concen-
trations were determined by nephelometry. For each 
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disappearance curve <l minimum of four consecutive 
point'i wus used_ The log<lfithms of the Intralipid con-
centratiom were plotted against time. Strdight lines 
were obt<-1ined from which the corre!<-1tion coefficients 
were calculated. Steady state plasma lntralipid concen-
trations were estimated by nephelometry as well. 
The posthep;1rin LPL activities were measured 5 
minutes after the intravenous injection of 100 U of 
heparin/kg body weight. The measurement of post-
heparin LPL <tclivity h<ts heen described previously 
(5). 
RESULTS 
The lntralipid blood levels remained rela· 
tively constant during the whole period of 
intravenous feeding. Initial value for IVFTT 
was 7.1 %/min. End value was 22.6%/min 
(Fig. 1). Correlation coefficients of the 
IVFTT curves were higher than 0.99 for 
each curve. Initial value for postheparin 
LPL was 50 11-Eq FA/min/!, end value 
3I7 ILEq FA/min/! (Fig.!). 
The triglyceride and cholesterol blood 
levels were determined before and after the 
intravenous feeding period and at the max-
imum lntralipid infusion rate. The trigiycer· 
ide levels were always within the normal 
range. though slightly higher during the in-
fusion period as compared with the prae and 
post infusion levels. 
The cholesterol levels were slightly lower 
during the infusion period as compared with 
the prae and post infusion levels. The pa· 
tient did not develop acetonuria, acidosis, 
or coagulopathy and the liver function tests 
remained normal. The weight of the patient 
increased 4 kg in 4 weeks. 
DISCUSSION 
The concentration of Intralipid in the plasma 
at any given time during constant infusion 
represents a balance between the rate of 
entry into the plasma and the rate of re-
moval. At a constant removal rate, the Intra· 
lipid blood levels depend on the rate of entry 
into the blood. The observation in our pa· _ 
tient that the plasma levels remained rela-
A era P~diarr Scand 63 
tively constant when the infused fat dose 
was brought up from 3 g to 8 g/kg body 
weight/day has to be explained by a rising 
rate of removal. This has been confirmed in 
our patient by the increase in postheparin 
LPL activity parallel to the increased fat 
removal as measured by the IVFTT. 
It is not clear which component of the 
intravenous feeding regimen caused this en-
zyme induction. Although no hormonal 
studies were performed in our patient hyper-
insulinaemia has been observed during intra-
venous alimentation (3). Enhanced insulin 
production could be responsible for the ana-
bolic response to parenteral feeding. Induc-
tion of LPL synthesis could be an aspect of 
this anabolic response. 
As for our patient, the change of fat 
tolerance observed during parenteral feeding, 
would have made the use of a standard fat 
infusion dose quite arbitrary. By controlling 
lipid blood levels during the intravenous 
feeding period it was possible on the one 
hand "to avoid hyperlipidaemia and on the 
other to take maximum benefit of the high 
caloric value of fat emulsions. 
Acta P~~tdiatr Scand 63 
REFERENCES 
1. Borresen, H. C.. Coran, A. G. & Knutrud. 0.: 
Metabolic results of parenteral feeding in neonatal 
surgery. Ann Surg, 172: 291, 1970. 
2. Carlson, L. A. & ROssner, S.: Methodological study 
of an intravenous fat tolerance test with intralipid 
emulsion. Scan J Clin Lab Invest, 29: 271, 1972. 
3. Genuth, S.: Insulin response to intravenous aiimenta-
tion.N£ng/1Med.289: 107,1973. 
4. Hallberg, D.: Elimination of exogenous lipids from 
the blood stream. Acta Physio/ Scand, 65: Suppl. 
254, 1965. 
5. Kelly. Th. F.: Rapid assay of labelled free fatty 
acids in a mixture of labelled lipids. J Lipid Res, 9: 
799, 1968. 
6. Roger, J.: Tolerance clinique, anatomique et bio-
logique de l'organisme aux perfusions d'emulsions 
de lipides chez ]'enfant. Extrait Ann Anesth Fran-
qaise, 7: 805, 1966. 
Submitted Dec. 6, 1973 
Accepted Jan. 18, 1974 
(P. F.) Dept. of Paediatrics 
Sophia-Children's Hospital and Neonatal Unit 
Erasmus University 
Rotterdam 
The Netherlands 
45 

Chapter Ill ( 4) 
UTILIZATION OF FAT EMULSION DURING TOTAL PARENTERAL 
NUTRITION IN CHILDREN 
P. P. FORGET. J. FERNANDES and P. HAVERKAMP BEGEMANN 
From the Department of Paediatrics. Sophia Children's Hospital and Neonatal Unit, 
Erasmus Vnirersity, Ronerdam, /he N('fherlands 
ABSTRACT. Forget, P., Fernandes, J, and Haverkamp Begemann, P. (Department of 
Paediatrics, Sophia Children's Hospital and Neonatal Unit, Erasmus University, Rotterdam, 
the Netherlands). Utilization of fat emulsion during total parenteral nutrition in children. Acta 
Paediatr Sca.nd, 64: 1111111111, 1975.-Tolerance for Intrallpld fat emulsion during total parenteral 
nutrition (PN) was studied in 6 children. The lntraUpld dose was monitored by the dally 
detennination of plasma Intralipid levels. Fat removal was investigated at the start of and 
during the PN period by the in~ravenous fat tolerance test (IVFTT) and by determining the 
plasma postheparin lipoprotein lipase (LPL) activity. When the plasma lntralipid levels 
exceeded a value of 100 mg/100 ml, hyper pre-{3 lipoprotelnaemia, hypertriglyceridaemia, 
hypercholesterolaemia and hyperphospholipldaemia appeared. During PN most patients 
showed marked increases of postbeparin LPL. Return to nonnal values occurred after 
discontinuation of PN. Maximal LPL activities were found to correlate signlflcantly with total 
daily caloric intake (r=0.95, O.OS<p<O.Ol). The Intralipid elimination constant hardly 
changed during PN, with the exception of patient 6, who showed a marked increase (from 7 to 
22 %). Conclusions of this study are as follows: First a high caloric intake during PN leads to a 
marked increaseofpostheparln LPL activity. Se<:ond, by menltoring plasmalntraJipid levels at 
100 mg/100 ml approximately, it is possible to adjust the Intralipid dose in order to prevent 
hyperllpaem!a and to take maximal benefit from rising fat tolerance. Thirdly the IVFTI 
appeared to be of little value to estimate the child's fat elimination capacity. 
KEY WORDS: Parenteral nutrition, hyperlipaemia, postheparin lipoprotein lipase, intravcn· 
ous fat tolerance test 
During the last few years, total parenteral nutri-
tion has been used on a wide scale in paediatric 
patients. 
The more generalised use of fat emulsions in 
intravenous feeding programs (I, 12) has made 
it possible to infuse solutions through perip-
heral scalp veins for prolonged periods. The 
use of small peripheral veins instead of a 
"central line" via a catheter located into a 
major calibre vein has well-known advantages. 
Phlebitis can early be detected and the risk for 
catheter-related complications can be avoided. 
Apart from the practical advantage of including 
fat emulsions in parenteral nutrition there are 
also theoretical reasons to justify its use. 
I. The presence offat in the intravenous fluid 
prevents the development of an essential fatty 
acid deficiency which otherwise develops 
rapidly during PN (16). 
2. It facilitates hypercaloric feeding because 
of the high calorie/volume ratio of fat emul-
sions. 
3. It precludes infusion ofunphysiologically 
high amounts of carbohydrates and 
aminoaciQs, otherWise needed to maintain a 
calorically adequate regimen. 
Both the advantages mentioned and the very 
low incidence of clinical side effects associated 
with the use of lntralipid (Vitrum) fat emulsion 
in adult patients (11) make its use in children 
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Fig. I. Total intravenous alimentation of a girl of 2 years 
with encephalitis. Aminoacids were not administered be-
cause it was necessary to restrict the volume intake. 
attractive. However, higher caloric needs ex-
pressed on a weight basis in children could lead 
to the use of a higher fat dose/kg body weight 
than in adults. Are these high doses devoid of 
clinical side effects? Is it possible to determine 
the fat tolerance of an individual child in order 
to adjust the quantity to be infused to the 
quantity he can tolerate. Little is known about 
the utilization and tolerance of fat emulsions in 
paediatric patients. The same Intralipid dose 
per kg body weight per day has been used by 
some authors with acute side effects (20) and by 
others without toxic effects (I). As we have 
stated earlier (7) toxicity seems to be associated 
with high lntralipid blood levels. High blood 
levels are found when the capacity of the en-
zyme lipoprotein lipase for fat elimination is 
exceeded. This happens when the lntralipid 
blood level exceeds a concentration of 100 to 
!50 mg/100 ml (101. 
At this point when the enzyme (LPL) is 
saturated with its substrate Ontralipidl. exces-
48 
sive fat doses are no longer eliminated by the 
physiological enzymatic removal mechanism 
but by aspecific uptake in RES and liver (20). 
In our preliminary study (7) in one patient we 
found that LPL is an inducible enzyme. The 
present paper reports the study of six patients, 
the first one included. Elimination capacity for 
fat was frequently checked during the PN 
period. Intralipid blood levels were checked 
d;:tily and the lntralipid dose adjusted in order to 
obtain an lntralipid blood level of 100 to 150 
mg/100 ml (LPL saturation level). Frequent 
controls of serum triglycerides, cholesterol 
concentrations, and of liver function tests were 
made. Free fatty acids and ketone bodies serum 
levels were followed in 2 patients. 
MA TERlAL AND METHODS 
Patients and in[11sion method 
Six patients were studied. We administered lntralipid 20% 
{Vitrum). Yamin (Vitrum). and glucose from separate bot-
tles simultaneously. at a constant rate around the clock. 
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Vitamins and minerals were added in adequate amounts 
(\2). All solutions were infused in a peripheral vein of the 
child. 
Lahoraror.· methods 
The intravenous fat tolerance test ( !VFTTl was carried out 
as described by Carlson & ROssner (3). For all tests a 20 7r 
lntralipid emulsion was administered intravenously in a 
dose ofO.l g fat/kg body weight. within one minute. Capil-
lary blood samples were collected every 5 minutes for 30 
minutes. The lntralipid concentration~ were determined by 
nephelometry. For each disappearance curve a minimum 
of four consecutive points wa~ used_ The logarithm~ of the 
lntralipid concentratiom were plotted against time. 
Straight lines were obtained from which the correlation 
coefficienh were calculated. Steady state pla;,ma lntralipid 
concentration.;; were estimated by nephelometry. These 
levels were ;,lightly overe~timated, no <tllowance being 
made for the fa'iting pla;,ma nephelometri<.: value which wa;, 
unknown during the infu~ion of fat emul'oion. 
The po'itheparin LPL activitie~ were mea~ured :'i mi· 
nute' after the intr<tvcnou' injection tll" 100 U hep<trin/kg 
hody weight. LPL activitie~ were mea~ured ac..:nrding It\ 
the methml of Kelly { 13) with minor mmli!ication~ {i{) 
Serum triglv<.:eride' concentratium 1\Cre determined ud 
modum S<.:hmtdt & nm Dahl !.:!2). Serum chole,terol con-
Ct:nlrdliom v.ere tktcrminn.illd mod11111 Ctrr & Drcktcr 
r 
Fi~t. 3. Total intravenous ali menta· 
tion of a boy of 8 years with en-
cephalitis. 
(4). Serum phospholipids concentrations were determined 
ad modum Zilversmit & Davis (23). Lipoprotein electrop-
horesis was performed ad mod am Postma & Stroes { 17). 
For the determination of serum free fatty acids we used the 
extraction method described by Royer (21) followed by 
titrimetric measurement according to Korovina ( 14) 
Serum ketone bodies were only qualitatively tested 
IKetostix. Ames). 
RESULTS 
The results of PN in patients 1-6 are shown in 
the corresponding Figs. 1-6. Other data, not 
shown in the figures, are as follows. 
Liver function tests, petformed weekly, re-
mained normal in all patients. Coagulopathy 
did not deyelop in any patient. Qualitative ex-
aminations for the presence of ketone bodies in 
the blood were frequently petformed in most 
patients. with negative results, irrespective the 
levels of blood lipids. In patients I and 2 
hyperlipaemia occurred. associated with the 
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Fig. 4. Total intravenous alimentation of a female infant of 
22 days with intractable diarrhea. 
appearance of an increased pre~J3 lipoprotein 
band on electropherograms. In patient 3 hyper 
pre-,B lipoproteinaemia appeared only on the 
20th and 2 l"st day of the PN period. Inpatients 5 
and 6, hyperlipaemia did not occur, even during 
high lntralipid doses. In both patients 5 and 40 
min postheparin LPL activities were meas-
ured; the 40 min values were equal to or lower 
than the 5 min values. 
DISCUSSION 
It can be seen from the results shown above 
that individual children widely differed in their 
tolerance for lntralipid: During PN some pa-
tients (I and 2) developed hyperlipaemia while 
receiving low quantities of fat whereas other 
patients (3, 4, 5, and 6} tolerated very high fat 
doses and thus seemed to be very resistant to 
the development of hyperlipaemia. Is it possi-
ble to predict, and thus avoid the development 
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of hyperlipaemia using as parameters either the 
postheparin LPL activity, the IVFTT, or the 
lntralipid blood levels? 
The relation between fat tolerance and the 
postheparin LPL activity should be discussed 
first. The postheparin LPL activity is of mixed 
origin as LPL has been found in extracts of 
many tissues such as adipose tissue, muscle, 
heart, spleen. lung, kidney medulla and lactat-
ing mammary gland ( 19). Moreover, a signific-
ant fraction of postheparin LPL seems to origi-
nate from the liver (15). The functional signifi-
cance of postheparin LPL activity is therefore 
not exactly known. It does, however, probably 
give an overall indication of the organism's 
capacity to eliminate triglyceride from the 
blood. 
Patient I in whom LPL was not determined, 
and patient 2 in whom no rise of LPL was 
found, tolerated only very small fat doses. Pa-
tients 3, 4, 5, and 6 showed very high posthepa-
rin LPL activities during PN and tolerated very 
high fat doses. Why did the postheparin LPL 
rise in some patients and not in others? To 
answer this question we looked for a correla-
tion between the quantities of nutrients 
administered intravenously and maximal post-
heparin LPL activities. We first calculated the 
means of the daily quantities of fat, 
carbohydrate and protein given to the patients 
in the 3 days preceding the enzyme determina-
tions. No correlation could be found between 
the intake of either fat, carbohydrate, protein 
or a combination of two of these nutrients on 
the one hand and postheparin LPL activity on 
the other hand. A good correlation coefficient 
(r=0.95, 0.05<p<0.0l) was found, however, 
between total caloric intake and postheparin 
LPL activity (Fig. 7). As it is known that LPL 
decreases with starvation, one could wonder 
whether the values at the start of the PN period 
could have been subnormal and have risen to 
normal during PN. This is not the case, since 
the initial values in our patients fall within the 
normal range found in our laboratory 
(82.8±32.4, n=4)and secondly because high 
LPL values during PN in patients 4 and 5 
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decreased to the normal initial values after 
complete oral re-alimentation. A high caloric 
intake (probably accompanied by changes in 
insulin production) thus seems to induce synth-
esis of more enzyme. As no correlation could 
be found between fat intake and postheparin 
LPL, it seems that the increased enzyme 
synthesis does not result from a specific fat 
inducement but is part of a more generalised 
anabolic effect of high-caloric PN. 
The second question to be discussed con-
cerns the relation between fat tolerance and the 
outcome of the IVFTT. With the exception of 
patient 6 who showed a threefold rise of fat 
elimination as measured by the IVFTT. all 
patients, while tolerating very different fat 
doses and some showing substantial rises in 
postheparin LPL activity. only showed slight 
deviations of IVFTT within the normal range 
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Fif!. 5. Total intravenous alimenta-
tion of a girl of 13 months with in-
tractable diarrhea. 
for children (8.39± 1.66. n = 10). Thus. the 
IVFTT did not give a good evaluation of the 
organism's total fat removal capacity. One 
reason for this could lie in the fact that the fat 
dose used in the IVFTT was too low. By giving 
such a low dose one probably only makes use of 
the small, directly available fraction oft he total 
LPL pool that might be located on capillary 
endothelium "receptors" as suggested by 
Robinson & Wing (18). This small fraction 
probably does not rise during PN. Support for 
the supposition that the IVFTT did not rise 
because of the low fat dose used in the test may 
be found it"J a recent" study of intralipid elimina-
tion in preterm and small-for-date babies (9). 
With a !ow fat dose (such as we used) lntralipid 
elimination curves were not significantly dif-
ferent in the two groups of patients. When a 
higher dose 10.5 g/kg body weight) was used, 
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small-for-date babies showed a decreased fat 
tolerance, is compared with the preterm in-
fants. 
The last question to be discussed concerns 
the relation between fat tolerance and the ln-
tralipid blood levels. In our patients, 
hyperlipaemia developed whenever Intra!ipid 
blood levels exceeded a value of about 100 
mg/100 mi. This level corresponds with the 
LPL saturation level as described by Hallberg 
(10). It is noteworthy that the hyperlipaemia 
which occasionally developed was not limited 
to triglycerides but involved cholesterol and 
phospholipids, too. At the same time, hyper 
pre-{3 lipoproteinaemia could be demonstrated 
on electropherograms. This can be explained 
by our hypothetical model of fat elimination 
during PN. 
Fat elimination, when no saturation of the 
LPL system occurs, is depicted in Fig. 8. 
Circulating lntralipid can be eliminated in two 
different ways. First, by the well-known 
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physiological removal mechanism involving 
the LPL enzyme system probably located in 
the capillary endothelium of peripheral tissues 
( 19). This enzyme splits triglyceride molecules 
into glycerol and free fatty acids. Most of the 
fatty acids that are liberated are deposited in 
adipose tissue after local resynthesis into 
triglycerides. The rest remains in the blood 
stream, is taken up by the liver and secreted 
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FiK. 8. Hypothetical model for Intralipid metabolism dur-
ing PN when LPL is not saturated. 
back into the blood as pre-,B lipoprotein. LPL 
being unsaturated. the latter is normally elimi-
nated and no hyperlipaemia ensues. The sec-
ond elimination mechanism involves direct 
aspecific uptake off at in RES (5) and liver (20). 
Direct liver uptake probably plays only a minor 
physiological role, as it has been demonstrated 
that there is very little net uptake of intact 
chylomicrons by the liver in rats (6). Here again 
fat is transformed by the liver into pre-/3 
lipoprotein. which is secreted into the blood 
and normally eliminated because LPL is un-
saturated. 
Fat elimination when saturation of LPL oc-
curs is depicted in Fig. 9. Surplus fat exceeding 
the LPL-related removal mechanism is slowly 
eliminated by the second aspecific mechanism 
for fat removal. Endogenous triglyceride sec-
reted by the liver cannot be efficiently elimi-
nated LPL being saturated. Hyper pre-13 
lipoproteinaemia develops accompanied by a 
Adipo>e tluue 
Moxlmol - FFA/ 
rise of its three lipid components, viz. 
triglycerides. cholesterol and phospholipids. 
This model assumes the existence of a common 
saturable triglyceride removal mechanism for 
both exogenous and endogenous triglycerides. 
Evidence for this may be found in a recent 
study of hyperlipaemic patients (2). The pres-
ence of high serum free fatty acid levels in 
patients 3 and 5 is in agreement with the hypot-
hetical model. It should be pointed out that 
ketosis did not occur. The presence of elevated 
serum free fatty acid levels unaccompanied by 
ketosis can be ascribed to the fact that glucose 
was infused simult_aneously. 
The following conclusions may be drawn 
from this study of Intralipid utilization in 
children. First. by controlling Intralipid blood 
levels daily and keeping these below 100 
mg/100 ml during total PN one can adjust the 
lntralipid dose to the individual child's toler-
ance and thus take maximum advantage of the 
hydroly<i> by \ 
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high caloric value of fat emulsions without the 
risk of inducing hyperlipaemia. Second. as 
caloric restriction seems to be incompatible 
with a normal-to-high fat elimination capacity, 
one should be very cautious in the use of fat 
ernul sions in children who for whatever reason 
receive a limited caloric intake during PN. 
As a general rule, it seems advisable to start 
PNwith a low daily fat dose and relatively high 
carbohydrate and protein intake. Then, ln-
tralipid blood levels being kept below 100 
mg/100 ml by daily control, fat doses can be 
raised progressively. Subsequently, the major-
ity of patients will develop an increasing post-
heparin LPL activity coupled with an increased 
tolerance for fat, till, in the end, they tolerate 
daily fat doses of 4-6 g/kg body weight. 
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Addendum! 
The relative triglyceride production rate of patients with glycogen storage 
disease 
After publication of our manuscript entitled 'Triglyceride clearing in glycogen storage 
disease' more work on the IVFTT seemed to justify its use for the calculation of relative 
triglyceride production rate. These calculations have been performed retrospectively in 
the same way as set forth in chapter 2. They are presented and discussed in this adden-
dum. Triglyceride production rate appears to be elevated in most patients with GSD when 
compared to values of control subjects (Fig. 1). The highest values were found in patients 
with a glucose-6-phosphatase deficiency. 
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Triglyceride production rate in children with GSD and in control subject. 
When the results of triglyceride production and triglyceride removal of patients with GSD 
are put together the following can be concluded. The hypertriglyceridemia of patients 
with a deficiency of glucose·6·phosphatase or a de branching enzyme can be ascribed to 
both an increased production (Fig. 1) and a decreased fractional removal of plasma tri-
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glycerides (see paper !). The hypertriglyceridemia of patients with a deficiency ofthe 
phosphorylase system is mainly due to increased plasma triglyceride production. Con-
sidering these results and the fact that a diet rich in polyunsaturated fat is known to 
improve triglyceride removal (Neste] and Barter, 1973) and increase plasma PHLPL activ-
ity (Cybulska et aL, 1974), the effects of different diets on plasma lipids in children with 
GSD can be defined as follows: A high-carbohydrate low-fat diet in patients with a 
glucose-6-phosphatase deficiency can be expected to lower the triglyceride production 
rate (by decreasing the enhanced fasting liponeogenesis and by lowering lipolysis) and 
lower TG removal concomitantly. The reverse holds for a high-fat low-carbohydrate diet. 
The resulting plasma TG concentration depends on which of these two regulating proc-
esses is most affected. As these children do better on a high-carbohydrate diet it can be 
presumed that in these patients increased TG production plays the predominant role in 
the development of hypertriglyceridemia. 
In patients with a de branching deficiency or a phosphorylase deficiency, a high-fat diet 
will lower TG production (by decreasing enhanced postprandial liponeogenesis) and 
increase TG removal. The reverse occurs on a high-carbohydrate low-fat diet. The syner-
gistic effect of diet therapy on both processes regulating plasma TG levels in the latter 
two groups of children explains why a low-carbohydrate high-polyunsaturated-fat diet 
influences favourably their plasma lipid abnormalities. 
56 
Addendum!! 
Plasma postheparin lipoprotein lipase activity during total parenteral nutri-
tion before and after introduction of lntralipid 
In paper 4 we showed that plasma PHLPL activity rose during total PN in some patients, 
whereas in other patients it did not. The following investigations were performed to study 
more closely the mechanisms involved. 
The patient was an 11 year old boy suffering from anorexia nervosa who was treated by 
total parenteral hypercaloric nutrition for a few weeks. During the first 9 days of PN no 
fat was infused. From the 1Oth day onwards Intralipid was introduced in the intravenous 
regime. The daily dose was increased stepwise as described in paper 4. Plasma PHLPL 
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activity was measured several times during the whole perioq. As we suggested that the 
insignificant rise of the IVFTT value during total PN could be due to the low lntralipid 
test dose used (paper 4), the IVFTT was modified and a higher fat dose of 0.3 g/kg body 
weight was administered. Serum triglyceride levels were followed for 2 hours after the fat 
emulsion had been injected. 
Plasma PHLPL activity decreased to abnormally low values while the patient received 
fat-less high-carbohydrate hypercaloric intravenous nutrition (Fig. 1). The activity rose to 
li.igh values after fat introduction (Fig. 1). Results of plasma triglyceride curves and 
lipoprotein electrophoresis before and on the 19th day of PN are shown in Fig. 2, 3, and 
4 (Intralipid standard curve being non linear at high concentration nephelometry was not 
performed). The TG curve performed before PN (low PHLPL activity) showed high TG 
bloodlevels (Fig. 2) while lipoprotein electrophoresis which was normal at the start 
showed an increased pre-~ band and a chylomicron (Intralipid) band 2 hours after fat 
injection (Fig. 3). The TG curve performed on the 19th day of PN was flat (Fig. 2). 
Lipoprotein electrophoresis at the start and 2 hours after fat injection were both normal 
(Fig. 4). 
The dependence of PHLPL activity on fat intake has been documented earlier (Fredrick-
son et al., 1963). Mancini et al. (1973) further showed that a high-carbohydrate low-fat 
diet given to adults fed orally resulted in a significant decrease of PHLPL activity. In 
paper 4 we showed the dependence of PHLPL activity on caloric intake. Results obtained 
in the present investigation make it very likely that the PHLPL activity during total PN 
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depends on both caloric and fat intake. Results of fat tolerance tests show that high 
PHLPL activities are associated with a better fat removal. This is best illustrated in 
Figures 2, 3, and 4. Postheparin plasma contains lipolytic enzymes of hepatic and extra-
hepatic origin (Krauss et al. 1973, Jansen et al., 1973) b. During total PN both fat 
removal and PHLPL activity increase. The following assays performed in plasma samples 
of this patient point to the extrahepatic tissues as main contributors to increased plasma 
PHLPL activity in tbis condition. 
a. On the basis of immunological differences between hepatic and extra-hepatic PHLPL 
an antiserum against human hepatic lipase has been developed by Jansen (1973b). 
Using this antiserum it was found that 94% of the PHLPL increase of our patient's 
plasma during PN was of extrahepatic origin (Jansen and Forget, unpublished). 
b In our patient's postheparin plasma the ratio of triacylglycerolhydrolase activity to 
palmitoyl-CoA hydrolase activity was calculated and found to increase after the 
introduction of fat in the PN regime. In the rat a high ratio has been found to reflect a 
high extrahepatic contribution to plasma postheparin lipolytic activity (Jansen and 
Hulsmann, 1974). Extrapolating from rat to man, it is likely that the extrahepatic 
tissues are the main contributors to the increased PHLPL activity during total PN. 
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Chapter IV 
General discussion and speculation 
In order to interpret the results as a whole, we will present in this chapter a hypothetical 
model of plasma triglyceride metabolism and show how our results fit into it. The model 
presented is based on two assumptions. 
Muscular tissue plays the predominant role in plasma triglyceride removal, as has been 
found by Kaijser and Rossner (1974), who studied the 'extraction of exogenous tri-
glycerides in human forearm muscle and subcutaneous tissue'. 
2 Adipose tissue contributes much more than muscular tissue to plasma PHLPL activity. 
Although there is, at present, no firm evidence to prove this, the following data give 
some support to this hypothesis. 
a. Total starvation in obese patients has been shown to bring about a 50% decrease of 
PHLPL activity (Huttunen, 1974) and a decrease of adipose tissue LPL activity 
(Persson, 1970). Still, during total starvation of these obese patients Intralipid 
removal was found to increase slightly (Huttunen, 1974). This author suggested 
increase of triglyceride removal by muscle to compensate for decrease of triglyce-
ride removal by adipose tissue. If in this situation muscle LPL activity is increased it 
is apparent that this did not prevent a decrease of total PHLPL activity during total 
starvation. Consequently, while muscle triglyceride removal probably compensates 
for decreased triglyceride removal by adipose tissue, it does not seem to compen-
sate for decreased plasma PHLPL activity. This could mean that the quantitative 
contribution of muscle to plasma PHLPL activity is small. 
b In obese children we found a significant correlation between the degree of adiposity 
and plasma PHLPL activity. This again, suggests that adipose tissue is the main 
contributor to plasma PHLPL activity. 
If these 2 assumptions are correct, the following conclusions can be drawn: while the 
IV FIT measures the fractional triglyceride removal as a whole, the plasma PHLPL activ-
ity mainly reflects that part of the removal process which takes place in adipose tissue. 
The quantitative importance of the latter would be less thar; that of muscular tissue 
according to Kaijser and ROssner, 1974. 
Taking these two assumptions into account the following model for plasma triglyceride 
metabolism can be presented (see Figure). The line connecting the liver to the plasma TG 
pool represents TG production (intestinal production, being minimal in the fasting state, 
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is not represented in the Figure). The greater 'muscle' area indicates the predominant 
function of muscle in plasma triglyceride removal. It should be pointed out that the 
muscle and adipose tissue areas shown in the Figure only reflect the fractional triglyceride 
removal of these tissues and do neither represent the masses nor the total TG removal of 
these respective tissues. It should be stressed that, assuming steady state plasma TG levels, 
TG production is equal to total TG removal. Consequently, a decreased fractional TG 
removal is compatible with a normal or increased total TG removal (not represented in 
the Figure) in situations where TG production is either normal or increased. How the 
results of our few investigations fit into this model is shown in the Figure. 
The conclusions of our first study (paper I) performed in patients with glycogen storage 
disease can be summarized as follows. In GSD, plasma TG production being increased, 
total plasma TG removal is increased accordingly (paper I, and addendum 1). The low 
PHLPL activities found indicate, according to our second assumption, a low adipose 
tissue LPL cOntent. Low plasma insulin concentrations, such as found in glucose~6-
phosphatase-deficient children (Lockwood et al., 1969) could be responsible for this low 
adipose tissue LPL content as insulin is known to regulate adipose tissue LPL (Borensz-
tajn, 1973). On the other hand, high plasma glucagon levels, as might be present in these 
children could increase muscle LPL (Borensztajn, !973). A low adipose tissue, high 
muscle LPL content would be compatible with a low total TG removal in adipose tissue 
compensated by a high total TG removal in muscle. 
Results of paper 2 performed in obese children can be summarized as follows. Triglyce-
ride production has been found to be normal or (more rarely) increased. Triglyceride 
fractional removal in hypertriglyceridemic obese children was significantly decreased, 
plasma PHLPL activity was increased, and significantly correlated with the degree of 
obesity. This situation is depicted in the Figure. Triglyceride production is shown to be 
normal or slightly increased. Triglyceride fractional removal is shown to be increased in 
adipose tissue and markedly decreased in muscle. Consequently, the !VFTT value is 
decreased. The lack of correlation between the !VFTT values and plasma PHLPL activ-
ities in these children suggests that in this situation removal blocks at other sites 
(probably muscle) than adipose tissue most probably account for the decreased !VFTT 
values. The higl1 plasma PHLPL acitivity probably reflects high adipose tissue LPL 
content (assumption 2). Consequently, triglyceride removal by adipose tissue is probably 
increased. 
The following litterature data give some support to this hypothesis. Schade (1974) 
reported obesity to be characterized by an increased insulin and a decreased glucagon 
secretion. According to studies performed in the rat (Borensztajn, 1973), this could result 
in a high adipose tissue, low muscle LPL content. Similar findings, in obese children, 
could be responsible for a low muscle, high adipose tissue triglyceride removal. 
Results of our last study performed in total parenteral nutrition (papers 3 and 4, 
addendum 2) showed that, during total parenteral nutrition with fat emulsion, plasma 
PHLPL activity rose as well as triglyceride removal capacity (higher tolerance) in those 
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children receiving a hypercaloric regime. This situation is depicted in the Figure. Triglyce· 
ride production is shown to be slightly increased. 
This might result from the high plasma FFA found during total PN (see paper 4). Tri· 
glyceride fractional removal is shown to be normal in muscle and probably greatly 
increased in adipose tissue. Consequently, the fractional triglyceride removal is increased. 
We think this conclusion to be warranted in spite of the fact that we could not demon· 
strate a 'significant' rise of the IVFTT values in these children. The very high plasma 
PHLPL activities found in some patients are compatible with a high LPL content of 
adipose tissue (see assumption 2). This results in an increased triglyceride removal in 
adipose tissue 
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Summary 
This thesis aimed at investigating some aspects of plasma triglyceride metabolism in 
children. In the introduction general aspects of plasma triglyceride metabolism are presen-
ted. 
Chapter 1 reviews recent litterature data on the intravenous fat tolerance test and on 
plasma postheparin lipoprotein lipase activity (PHLPL) in different situations associated 
with abnormal plasma triglyceride concentration. 
Chapter 2 defines the subjects of investigation. They are: 
1 Plasma triglyceride metabolism in children with glycogen storage disease. 
2 Plasma triglyceride metabolism in obese children. 
3 The use of lntralipid fat emulsion during total parenteral nutrition. The methods used 
in these investigations are described. They are the intravenous fat tolerance test 
(IVFTT) and the measurement of plasma PHLPL activity. A method for calculating 
relative triglyceride production rate is also presented. 
In chapter 3 the following papers are presented. 
1 Triglyceride clearing in glycogen storage disease 
The results point to a relative inefficiency of plasma triglyceride removal in patients with 
glucose-6-phosphatase deficiency or de branching enzyme deficieny. Patients with a 
deficiency of the phosphorylase system showed normal results. After publication of this 
paper, more work on the IVFTT seemed to justify its use in the calculation of relative 
triglyceride production rates. These calculations have been performed retrospectively and 
are presented in an addendum (I). In short, triglyceride production rates were found to be 
elevated in all three groups of patients with glycogen storage disease investigated. Our 
conclusions are as follows: 
The hypertriglyceridemia of patients with a deficiency of glucose-6-phosphatase or of 
de branching enzyme can be ascribed to both increased production and decreased removal 
of plasma triglycerides. The hypertriglyceridemia of patients. with a deficiency of the 
phosphorylase system is due to increased plasma triglyc"eride production only. 
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2 Plasma triglyceride metabolism in obese children 
In 13 obese cltildren plasma triglyceride concentrations were found to be significantly 
increased above normal while plasma cholesterol concentrations were normal. In the 
hypertriglyceridemic obese children, the plasma triglyceride removal, measured by the 
intravenous fat tolerance test was significantly decreased. A few patients showed an 
increased triglyceride production. These abnormalities reverted to normal in all patients 
retested after weight loss. Plasma PHLPL activity was found to be increased and signifi-
cantly related to the degree of obesity. As for carbohydrate metabolism a decreased 
glucose tolerance and hyperinsulinemia were found. Hyperinsulinemia reverted to normal 
during dietary restriction, glucose intolerance did not. 
These results are further discussed. 
3 Enhancement of fat elimination during intravenous feeding 
It is shown in this paper that a rise in plasma PHLPL activity occurred during longterrn 
parenteral nutrition with fat emulsion in a patient with anorexia nervosa. This rise was 
accompanied by a rising tolerance for fat emulsion and a rise of the IVFTT value. This 
preliminary work prompted further study of this problem in more patients. 
4 Utilization of fat emulsion during total parenteral nutrition in children 
The rise of plasma PHLPL activity accompanied by a rise in fat tolerance has been 
confirmed in most cltildren investigated. The IVFTT value did not increase invariably, 
however. Interpretation of these results is presented. It is further shown that when 
Intralipid tolerance is exceeded hyperlipemia ensues. Tolerance is shown to be exceeded 
when a 'critical' Intralipid bloodlevel is surpassed. By controlling lntralipid bloodlevels 
during total parenteral nutrition it is possible to adapt the daily fat dose infused to an 
individual child's tolerance. Studies performed in another patient are presented in 
addendum II. It is shown that total PN without lntralipid resulted in a decrease of plasma 
PHLPL activity. Introduction of Intralipid induced a very significant rise of plasma 
PHLPL activity while fat tolerance increased simultaneously. Arguments are presented, 
which point to the extrahepatic tissues as site of origin of the augmented plasma PHLPL 
activity during total PN. 
In chapter 4 the results are discussed in a general context. A model of plasma triglyceride 
metabolism is presented. It is shown how the results obtained in our different investi-
gations fit into this model. 
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Samenvatting 
Enkele aspecten van de plasma triglyceride stofwisseling vormen het onderw~rp van dit 
proefschrift. Algemene aspecten van de plasma triglyceride stofwisseling worden be-
sproken in de Introductie. 
Hoofdstuk 1 geeft een litteratuuroverzicht over de intraveneuze vettolerantie test 
(!VFTT) en de plasma postheparine lipase (PHLPL) activiteit in verschillende situaties die 
gekenmerkt zljn door verhoogde plasma triglyceride concentraties. 
Hoofdstuk 2 beschrijft de verschillende onderdelen van deze studie. 
Deze zijn: 
I Plasma triglyceride stofwisseling bij kinderen met glycogeenstapelingsziekte. 
2 Plasma triglyceride stofwisseling bij kinderen met vetzucht. 
3 Het gebruik van Intralipid vetemulsie gedurende volledige parenterale voeding. De 
gebruikte methoden zijn beschreven. Deze bestaan uit de IVFTT en het meten van de 
plasma PHLPL activiteit. Een methode voor het berekenen van de relatieve plasma 
triglyceride productie is beschreven. 
Hoofdstuk 3 bevat de volgende publicaties: 
1 Triglyceride clearance in glycogeen stapelingsziekte 
De resultaten wijzen erop dat paW:inten met een glucose-6-phosphatase of een de-
branching enzym deficH~ntie een verlaagde plasma triglyceride eliminatie hebben. Normale 
resultaten werden verkregen bij patH~nten met een deficientie van het phosphorylase 
systeem. Nadat deze studie gepubliceerd was, maakte recente literatuur over de intra· 
veneuze vettolerantie test het mogelijk om deze laatste te gebruiken voor het berekenen 
van de relatieve triglyceride productie. Retrospectief zijn deze berekeningen gedaan, en 
weergegeven in addendum I. Samenvattend, werd er een verhoogde relatieve triglyceride 
productie gevonden in alle drie bestudeerde patientengroepen met glycogeen stapelings· 
ziekte. Onze conclusies zijn als volgt: Hypertriglyceridemie bij patienten met deficientie 
van glucose·6·phosphatase of van de branching enzym wordt veroorzaakt door zowel een 
verhoogde triglyceride productie als een vertraagde triglyceride eliminatie. Hypertriglyce· 
ridemie bij patienten met een deficientie van het phosphorylase systeem wordt uitsluitend 
veroorzaakt door een verhoogde triglyceride productie. 
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2 Plasma triglyceride stofwisseling bij kinderen met vetzucht 
Wij vonden bij 13 zeer dikke kinderen een significante verhoging van de plasma tri-
glyceride concentraties. De plasma cholesterol concentraties waren normaal. Er werd een 
significante verlaging van de plasma triglyceride eliminatie (gemeten door middel van de 
IVFTT) gevonden bij dikke kinderen met hypertriglyceridemie. De triglyceride productie 
was slechts verhoogd bij enkele dikke kinderen. Deze afwijkingen normaliseerden na 
vermagering. De plasma PHLPL activiteit was verhoogd en bleek significant gecorreleerd 
met de mate van vetzucht. Wat betreft de koolhydraat stofwisseling, werden een ver-
rninderde glucose tolerantie en hyperinsulinemie gevonden bij dikke kinderen. Na ver-
magering werd de insuline spiegel weer normaal, de glucose intolerantie bleef echter 
onveranderd. Deze resultaten worden besproken. 
3 Verhoging van de veteliminatie gedurende volledige intraveneuze voeding 
Deze publicatie laat zien dat de PHLPL activiteit omhoog ging gedurende totale parente-
rale voeding van een patient lijdende aan anorexia nervosa. Deze verhoging ging gepaard 
met een verhoging van de tolerantie voor Intralipid vetemulsie en van de IVFTT con-
stante. Deze preliminaire studie leidde tot verder onderzoek van dit phenomeen in andere 
patienten. 
4 Gebndk van vetemulsie bij kinderen gedurende volledige intraveneuze voeding 
In de meeste kinderen steeg de plasma PHLPL activiteit en dit ging gepaard met een 
toenemende tolerantie voor vetemulsie. De verhoging van de IVFTT constante werd niet 
bij aile patienten gevonden. Deze verschillen worden verder besproken en er wordt verder 
op gewezen, dat wanneer de Intralipid tolerantie werd overschreden er hyperlipemie 
ontstond. Deze lntralipid 'intolerantie' ontstond wanneer de lntralipid bloedspiegels 
hager waren dan de zogenaarnde kritische concentratie. Door het dagelijkse controleren 
van lntralipid bloedspiegels gedurende totale parenterale voeding is het mogelijk de dage-
lijks te infunderen vetdosis aan te passen aan de individuele tolerantie van het kind. 
Onderzoek bij een laatste patient is gepresenteerd in addendum II. Er wordt hierin 
gedemonstreerd dat parenterale voeding zonder Intralipid resulteerde in een daling van de 
plasma PHLPL aktiviteit. Completering van volledige intraveneuze voeding met Intralipid 
induceerde een zeer significante verhoging van de plasma PHLPL activiteit en een ver-
hoging van de tolerantie voor Intralipid. Verder worden argumenten naar voren gebracht 
die de hypothese steunen dat de verhoogde PHLPL die gevonden werd tijdens totale 
parenterale voeding afkomstig is van de extra-hepatische weefsels. 
De resultaten van deze verschillende onderzoekingen worden besproken in hoofdstuk 4. 
Modellen van de plasma triglyceride stofwisseling in de door ons onderzochte situaties 
worden weergegeven. 
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